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LEVELS OF SERUM URIC ACID AND RISK OF MYOCARDIAL INFARCTION 
AMONG GOUT PATIENTS 
ABDALLA ALI ABDUSSAMAD 
ABSTRACT 
   
 
       Objective: Our aim in this study to determine if serum uric acid level measured at 
baseline is a risk factor to develop Myocardial Infarction among people diagnosed with 
gout. 
Method: This was a retrospective cohort study, which used the THIN (The Health 
Improvement Network), an electronic medical records database from the UK. Obtained 
were SUA levels at baseline after gout diagnosis and follow-up till time of event. We 
performed Cox proportional hazard regression models to examine the relation of SUA 
levels to risk of incident MI for men and women separately, and the multivariable 
regression model. 
Results: There were 12,180 individuals included in this study, of them, 70% (n=8539) 
were men. There were 200 events of MI, 145 in men and 55 in women. SUA were not 
associated with risk of MI in unadjusted and adjusted multivariable regression model, the 
crude HR of MI in men were 1.27 (95% CI: 0.70-2.30), 0.97 (95% CI: 0.56-1.69), 0.83 
(95% CI: 0.47-1.46), and 1.07 (95% CI: 0.62-1.84), respectively, for each increased SUA 
categories. No change observed after full adjustment. Similar results were also observed 
in women. 
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Background of Gout and Hyperuricemia 
 
Uric Acid 
       Uric acid is an end product of the break down of compound called purine (Figure.1).1 
Purines (adenine and guanine) are chemical compounds serve crucial roles in many body 
biological processes, by producing some important bioactive molecules, these molecules 
play a major role in genetic materials synthesis, protein synthesis, energy molecules 
production, and can act as mediators in nervous system2-4. The main sources of purines 




       Under normal circumstances the body eliminates excess uric acid production through 
the kidney and the gut, which helps to keep serum urate concentrations below the limit of 
solubility point, i.e., 6.8 milligram per deciliter (mg/dl) at normal body temperature and 
PH 4-7. Women have relatively lower levels of serum uric acid concentration than men 
because of premenopausal effect of estrogen, which reduces reabsorption of uric acid by 
the kidneys. This explains why women are at lower risk to develop hyperuricemia at 














FIGURE.1 Purines Metabolism and Uric Acid Production 
 
Hyperuricemia 
       Hyperuricemia is an abnormally high level of serum uric acid greater than 6.8 mg/dl. 
6, 10, 11
 This occurs because either uric acid production increases or, more often, the 
kidney is unable to remove uric acid from the body well enough. 5- 7, 12 Hyperuricemia is 
present in about 5% of the population. 17 Over time, hyperuricemia may remain as 
asymptomatic, or progress to gout, urolithiasis (formation of stone in the kidney), or 















       Gout is a metabolic disorder caused by a buildup of uric acid in the blood.  The 
excess uric acid (a normal waste product) collects in the body, and precipitate to form 
needle‐like urate crystals deposit in and around the joints causing swelling and pain.  
Over time, these crystals can attract white blood cells leading to severe, painful gout 
attacks and chronic arthritis. 6, 7, 12-15 The peak incidence of gout occurs in patients 30 to 
50 years old, and the condition is much more common in men than in women. 6, 7, 13, 14   
Gout progresses through four clinical phases: asymptomatic hyperuricemia, acute gouty 
arthritis, intercritical gout (intervals between acute attacks), and chronic tophaceous gout. 
6, 7, 12-15 
 
Asymptomatic Hyperuricemia 
       Asymptomatic hyperuricemia is the condition in which the high levels of serum uric 
acid result without any clinical symptoms or signs of uric acid crystals deposition. 5, 12, 13, 
16
 Approximately 5-8 % of US adult, Caucasian males experience this condition. 16 Less 
than 30% of individuals with hyperuricemic will develop gout. 6, 7, 16 However, it can take 
ten to thirty years to experience a first acute gout attack. 16 Current clinical practice does 
not recommend treatment of asymptomatic hyperuricemia, but it is recommended to 
aggressively treat any accompany disease such as obesity, high lipid profile, high blood 
pressure, and diabetes millets. 17 These conditions are components of metabolic 
syndrome, which frequently associated with hyperuricemia, and it has high risk 
 4 




Acute Gouty Arthritis 
       In the early stages, gout commonly presents as single joint pain, typically big toe 
joint pain called podagra, later it might affects more joints. Gout attacks usually begin at 
night with joint pain, swelling, and redness, then subside spontaneously without treatment 
within 1-2 weeks. Over time, gout attacks tend to involve more joints, become more 
frequent and less acute, and last longer. 6, 7, 12-15 
 
Intercritical Gout 
       Following recovery from acute gouty arthritis, the patient reenters an asymptomatic 
phase of the disease. This phase is referred to as “intercritical gout.  At the beginning, this 
period my last for several years, but as the disease progresses this interval tends to 
become shorter. 6, 7, 12-15 The intercritical gout phase is perfect time for physicians to do 
additional work-ups to screen for the cause, any accompanying disease, and to start 
treatment. 13, 19 
 
Chronic Tophaceous Gout 
       As gout continue to progress, the periods between gout attacks are no longer 
symptom free. This may take more than 10 years to develop. 13 The main features of this 
stage are joint damage, chronic pain, disability, and development of tophi (large deposits 
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of sodium urate) in and around joints and some other tissues such as tendons, heart 
valves, ears, and the breast. 7, 13, 15, 16, 19, 20 
 
Prevalence / Epidemiology of Gout 
       In general gout has become more prevalent in developed and developing countries 
such as the United States, United Kingdom, New Zealand, and China. 21-31 In the United 
States gout affects 1- 2% of the population, and approximately 6% of men over the age of 
80. 32 In the United Kingdom gout affects 7% of men age over 75 years of age. 7, 15, 29 It is 
more prevalent in men than in women, 6, 7, 15, 19, 26, 27, 29, 32 usually affects men over the age 
of 40, and menopausal women (over 65). 7, 15, 29, 33-35 Gout tends to run in family in 
approximately 40% of patients. 32 Data from epidemiological studies suggest that gout is 
associated with metabolic syndrome, 36-42 more specifically, with obesity, 42-45 
hypertension (high blood pressure), 44, 46-48 hyperlipidemia (high cholesterol and 
triglycerides) 49-55 and diabetes. 27, 37, 39, 56, 57 The risk of developing gout is also 
associated with certain dietary factors such as red meat, 58-63 and alcohol, 64-66, 68 and 
medications for instance, aspirin, 67 and thiazide diuretics. 27,43,68 
 
Hyperuricemia, Gout, and Cardiovascular Events (CVE) 
       Individuals with hyperuricemia or gout are at increased risk of developing traditional 
cardiovascular events, such as hypertension, kidney disease, diabetes, and metabolic 












Figure 2. A Risk Model for Hyperuricemia, Gouty Arthritis (gout), and Acute 
Myocardial Infarction 
 
Over the past several decades numerous studies have examined the association between 
hyperurecemia (and gout) and the risk of cardiovascular disease; however, the results 
were inconclusive. 
       In earlier cohort studies, findings regarding the association of hyperurecemia or gout 
with risk of ischemic heart disease (IHD) were mixed. 70-74 Some studies suggested that 
individuals with hyperuricemia or gout had an increased risk of IHD. Other studies, 
however, failed to confirm such an association after adjusting for known traditional 
cardiovascular risk factors.75-79 
       There has been recent renewed interest in the association between hyperuricemia and 
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prediction of cardiovascular events (CVE). Previous studies examining relation of SUA 
levels to the risk of CVD were conducted among either a healthy population (without 
gout) or a population at high cardiovascular risk, including those with type II diabetes, 
the overweight/obese, or patients with history of myocardial infarction. Yet serum uric 
acid failed to show an association in some studies, 80-82 while an association and ability to 
predict CV prognosis was evident in other studies. 83, 84 Despite the fact that gout has a 
high unfavorable traditional cardiovascular risk profile, the feasibility to measure SUA, 
and availability of several therapies targeting hyperuricemia, only a few studies evaluated 
serum uric acid level among patients with gout. 85, 90  In which used SUA as high or low, 
other study only calculate CVS mortality in general not specifically MI. It is important to 
determine if this relationship exist among people with gout because it may lead to new 
approach to aggressively screen and treat of high SUA. 
 
Specific Objective 
       In this study we propose to examine the association between levels of serum uric 
acid and risk of MI among gout patients. Few studies to date have examined the risk of 
MI among gout patients. 75, 86, 87 To date, studies of gout in relation to risk of MI have not 
associated whether serum uric acid level was associated with risk of MI among gout 
patients. 88, 89 Thus, this study sought to evaluate the relationship between baseline SUA 
and myocardial infarction among persons with gout.  The results of this study will help to 
establish the following: 
1- Determine if there is an association between SUA and risk of MI. 
 8 
2- Determine if there is a cut off point for SUA concentration that might increase the 




Study Population Database 
       This study was conducted used data collected from "The Health Improvement 
Network" (THIN) from the United Kingdom. THIN is a computerized medical record 
database of the UK population entered by a general practitioner (GP). Since the THIN 
data collection began in 2003, 578 clinical practices have contributed to this database, 
collecting data from approximately twelve million individuals. 91 The National Health 
System (NHS) in the UK requires every individual to be registered with a GP regardless 
of health status, thus the THIN database widely represents the general UK population. 91  
THIN includes anonymized, detailed clinical information about patient visits to their GP, 
such as a demographic information, diagnoses, medications, laboratory test results, 
socioeconomic status, and additional health information recorded systematically 
including height, weight, blood pressure, smoking, and alcohol consumption. 91 To code 
diagnoses and prescription medications, Read and Multilex classifications were used, 
respectively. 92, 93 Of note, Read and Multilex have been widely validated for use in 
pharmacoepidemiological research. 94, 95 The THIN database includes approximately 
5.93% of the total population of the United Kingdom. 94  THIN is a detailed dataset well 
suited for cost-efficient, generalizable studies of gout and cardiovascular diseases. This 
database contains detailed health histories for each individual from initial work-up, 













Figure 3. THIN Database  
 
Study Design 
       We conducted a cohort study to assess the relation of SUA levels to the risk of 
myocardial infarction among patients with gout using the THIN database.  
 
Study Population 
       Included in the analysis were subjects who met the following criteria:  
Inclusion criteria:  
1-   New diagnosis of gout: the gout diagnosis was established based on the 
recording of a relevant diagnostic code after at least two years of continuous 
enrollment in THIN without a gout diagnosis, in addition to use of one or more of 
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2- Age - 18 to 89 years. 
3- At least one SUA measurement either; 30 days before a gout diagnosis or within 
one year after the diagnosis.  
4- Registered in THIN data between 2000 and 2012. 
Exclusion criteria: 
1- Individuals who had MI before the gout diagnosis. 
 
Study Duration:  
       Follow-up for study subjects started on the date of measurement of first SUA and 
continued until: 
1- First myocardial infarction (MI). 
2- Age of 90 
3-  Death. 
4- Disenrollment in THIN database, or end of study period, whichever came first. 
 
Exposure Definition: 
       As mentioned above presence of one serum uric acid measurement is required to be 
including in this study. The baseline SUA levels were divided into five categories: <6 
mg/dl, 6-<7 mg/dl, 7-<8 mg/dl, 8-<9 mg/dl, and >9 mg/dl. In the case of having more 
than one SUA measurement, the closest value following the gout diagnosis was used. In 
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some cases there were only one SUA measurement before gout diagnosis which has been 
used if it happens within 30 days of gout diagnosis. 
 
Primary Outcome:   
       In the current study the primary outcome was a new diagnosis of first myocardial 
infarction (either non-fatal or fatal MI) using the READ diagnostic code (see 
supplement). These codes have been successfully applied in the study of MI morbidity 
and mortality. 98-105 
 
Covariate Assessment 
       Socio-demographic and lifestyle characteristics were collected in the database before 
the diagnosis of gout. This included sex, age, BMI, smoking and drinking status. 
Additionally, information about comorbidities that were thought as potential risk factors 
for myocardial infarction, were also recorded in THIN, including hypertension, diabetes 
mellitus, and chronic kidney disease. In the same manner, prescribed drug records for 
angiotensin converting enzyme inhibitors (ACEI), aspirin, beta-blockers, lipid lowering 
agents, anti-platelet agents, and diuretics were obtained. Information of covariates were 






Institutional Review Board (IRB) Review 
This study was determined to be exempt by the Institutional Review Board of Boston 
University Medical Campus and Boston Medical Center. 
 
Statistical Analysis 
 Baseline characteristics were compared across categories of SUA levels using analysis of 
variance (ANOVA) for continuous variables, and chi-squared tests for categorical 
variables.  
Sex-specific incidence rates of MI according to categories of SUA level were calculated. 
Cox proportional hazard regression models were used to examine the relation of SUA 
levels to risk of incident MI for men and women separately. In the multivariable 
regression model, adjustments were made for the following variables: age, body mass 
index category 106 (i.e., underweight <18.5 kg/m2, normal ≥18.5-<25 kg/m2, overweight 
≥25-<30 kg/m2, and obesity ≥30 kg/m2), smoking status (i.e., never, former, and current 
smoker) alcohol consumption (i.e., never, former, current drinker), medications (i.e., 
aspirin, ACEI, beta-blockers, anti-platelet agents, diuretics, and lipid lowering agents), 
and comorbidities (i.e., diabetes mellitus, hypertension, chronic kidney disease). For 
missing categorical variables, a missing category was created to indicate the missing 
value.  
 
       Several sensitivity analyses were performed to check the robustness of the study 
findings. These included: (1) consideration of SUA as a dichotomous variable (<6 mg/dL 
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versus >6) i.e. 6 is the general goal of antihyperuricemic medication; (2) exclusion of 
subjects with any missing values for smoking, alcohol use or BMI; (3) use of SUA 
measurement after uric acid lowering therapy (ULT) within one year after diagnosis of 
gout. 
 
       All analysis were conducted using SAS (Statistical Analysis System) 9.2, provided 





       Included were 12,180 individuals who met the definition of gout and who had at least 
one measurement of baseline SUA. Of them, 70% (n=8539) were men.  
 
       Baseline characteristics of men are shown in Tables 1. The average age at the time of 
study was 59 years. More than 70% of male subjects were overweight/ obese. Less than 
50% were non-smokers, while more than 75% were current alcohol drinkers. There were 
similar percentages of overall cardioprotective medication use in each group of SUA 
levels except for SUA ≥ 9, which showed a high percentage of overall medication use, 
for instance, more than 50 % of this group use diuretics. Prevalence of diabetes mellitus, 
and kidney disease within each group of SUA was similar, however, each group of SUA 
level tended to have high prevalence of hypertension (i.e. more than 53% of SUA ≥9 
group has hypertension). 
 
 
Table 1. Baseline Characteristics of Male Subjects (N= 8539) 
Baseline 
Characteristics 
Serum Uric Acid Concentration (mg/dL) p-value 
 <6 6-7 7-8 8-9 ≥9 
N* 
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*Number of subjects (N) 
**Standard Deviation (SD) 
***Body Mass Index (BMI) 





       Baseline characteristics of women are shown in Table 2. The average age was 69 
years. More than 75% of subjects were overweight or obese, and approximately 65% 
were current drinkers, and approximately 40% were current or ex-smoker. Medication 
use tended to vary within each group of SUA level, with diuretics being the highest 
percentage of medication use within each group (i.e. approximately 90 % diuretics user 
among SUA ≥ 9 group). Prevalence of hypertension within each group was higher than 
diabetes mellitus and kidney disease (i.e. more than 80% have hypertension among SUA 
≥9 group). 
 
Table 2. Baseline Characteristics of Female Subjects (N= 3641) 
Baseline 
Characteristics 
Serum Uric Acid Concentration (mg/dL) p-value 
 <6 6-7 7-8 8-9 ≥9 
N* 
 
















































































































































































































































*Number of subjects (N) 
**Standard Deviation (SD) 
**Body Mass Index (BMI) 
***Angiotensin converting enzyme inhibitors (ACEI) 
 
 
        During the follow up period, 200 subjects (145 men and 55 women) experienced an 
MI (Table 3). The average follow-up years (Time to first MI) was 4 years in men and 3.7 
years in women. The total years of follow-up in men was 33695 and 12588 in women, 
respectively. The incidence rate of MI for each of the SUA categories in men was 4.3, 
5.4, 4.2, 3.6, and 4.6 case per 1000 person years for SUA categories <6, 6-7, 7-8, 8-9, and 
>9 mg/dl, respectively. The corresponding incidence rate of MI in women was 3.7, 4.0, 













Male     
<6 1073 20 4666.6 4.3 
6- 7 1074 24 4420.3 5.4 
7- 8 2175 35 8347.4 4.2 
8- 9 2147 30 8433.8 3.6 
≥9 2070 36 7826.8 4.6 
     
Female     
<6 817 12 3284.0 3.7 
6- 7 574 9 2246.1 4.0 
7- 8 732 12 2697.0 4.5 
8- 9 643 12 2346.8 5.1 
≥9 875 10 3014.1 3.3 
Combined     
<6 1890 32 7950.6 4.02 
6- 7 1648 33 6666.5 4.95 
7- 8 2907 47 11044.5 4.26 
8- 9 2790 42 10780.6 3.90 
≥9 2945 46 10840.8 4.24 
*Myocardial Infarction 
 
     As shown in n Table 4, compared with subjects in the lowest category of serum uric 
acid, the crude hazard ratio of MI in men were 1.27 (95% CI: 0.70-2.30), 0.97 (95% CI: 
0.56-1.69), 0.83 (95% CI: 0.47-1.46), and 1.07 (95% CI: 0.62-1.84), respectively, for 
each of the SUA categories, respectively. Further adjustments for age and other 
covariates did not change the magnitude of association substantially. Similar results were 
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also observed in women. When data for men and women were combined, multivariable 
adjusted hazard ratios of MI were 1.18 (95% CI: 0.72-1.92), 1.06 (95% CI: 0.68-1.67), 
0.97 (95% CI: 0.61-1.54), and 0.93 (95% CI: 0.58-1.48), respectively.  
 
Table 4. Relationship between SUA and Risk of MI 
 Crude HR (95% 
CI) 
Age adjusted HR 
(95% CI) 
Multivariate adjusted 
HR *(95% CI)** 
Male    
<6 1.00 (referent) 1.00 (referent) 1.00 (referent) 
6-7 1.27 (0.70-2.30) 1.27 (0.70-2.30) 1.30 (0.72-2.36) 
7-8 0.97 (0.56-1.69) 1.05 (0.61-1.82) 1.11 (0.64-1.92) 
8-9 0.83 (0.47-1.46) 0.92 (0.52-1.62) 0.95 (0.54-1.69) 
>9 1.07 (0.62-1.84) 1.14 (0.66-1.97) 1.06 (0.60-1.87) 
    
Female    
<6 1.00 (referent) 1.00 (referent) 1.00 (referent) 
6-7 1.09 (0.46-2.60) 0.97 (0.41-2.31) 0.93 (0.39-2.25) 
7-8 1.20 (0.54-2.67) 1.00 (0.45-2.24) 0.98 (0.44-2.22) 
8-9 1.39 (0.62-3.09) 1.06 (0.48-2.38) 1.01 (0.44-2.29) 
>9 0.90 (0.39-2.07) 0.66 (0.28-1.54) 0.63 (0.26-1.52) 
Combined    
<6 1.00 (referent) 1.00 (referent) 1.00 (referent) 
6-7 1.23 (0.76-2.00) 1.21 (0.74-1.97) 1.18 (0.72-1.92) 
7-8 1.05 (0.67-1.65) 1.10 (0.70-1.72) 1.06 (0.68-1.67) 
8-9 0.97 (0.61-1.53) 1.02 (0.64-1.61) 0.97 (0.61-1.54) 
>9 1.05 (0.67-1.64) 1.03 (0.66-1.62) 0.93 (0.58-1.48) 
 *Adjusted for age, BMI, smoking, alcohol consumption, medications (aspiring, ACEI, 
beta blockers, anti-platelets, diuretics, and lipid lowering agents), comorbidities (type II 
diabetes, hypertension, and kidney disease). 
**CI= Confidence interval 
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       A sensitivity analysis was conducted to assess the association of SUA levels and risk 
of MI using hyperuricemia as a dichotomous variable (<6mg/dl versus ≥ 6mg/dl) (Table 
5).  In male subjects with hyperuricemia (SUA> 6mg/dl), the HR was 1.07 (95% CI: 
0.67-1.72) in the age adjusted model and was1.09 (95% CI: 0.68-1.75) in the multivariate 
adjusted model. In female subjects, the HR for the age adjusted and multivariate adjusted 
model was 0.91 (95% CI: 048-1.73) and 0.88 (95% CI: 0.45-1.71), respectively.  
 
Table 5. Relationship of Dichotomous SUA and Risk of MI 
 Crude HR (95% 
CI) 
Age adjusted HR 
(95% CI) 
Multivariate adjusted 
HR *(95% CI)** 
Male    
<6mg/dl 1.00 1.00 1.00 
>6mg/dl 1.00 (0.62-1.61) 1.07 (0.67-1.72) 1.09(0.68-1.75) 
Female    
<6mg/dl 1.00 1.00 1.00 
>6mg/dl 1.13 (0.60-2.15) 0.91 (0.48-1.73) 0.88 (0.45-1.71) 
Combined    
<6mg/dl 1.00 1.00 1.00 
>6mg/dl 1.06 (0.72-1.54) 1.08 (0.74-1.57) 1.03 (0.70-1.50) 
*Adjusted for age, BMI, smoking, alcohol consumption, medications (aspiring, ACEI, 
beta blockers, anti-platelets, diuretics, and lipid lowering agents), comorbidities (type II 
diabetes, hypertension, and kidney disease). 
**CI= Confidence interval 
 
 
1- A complete-data analysis was performed to examine the association between SUA 
levels and risk of MI. In this analysis, 2841 (2220 men and 621 women) 
individuals with missing information of smoking, BMI, and/or alcohol intake 
were excluded. Of the remainders (n=10354), 172 subjects developed MI during 
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the follow-up period, 123 occurred in men and 49 in women. Compared with 
subjects in the lowest category of SUA, the crude HRs of MI in each SUA group 
as 1.42 (95% CI: 0.74-2.73), 0.94 (95% CI: 0.50-1.74), 0.90 (95% CI: 0.49-1.69), 
and 1.24 (95% CI: 0.68-2.26), respectively, in men. Multivariable-adjusted HRs 
did not change significantly. Women subjects showed similar pattern in crude and 
adjusted model. Excluding missing categories did not change the results of our 
primary analysis. 
 
Table 6. Relationship between SUA and Risk of MI After Excluding Missing Data 
 Crude HR (95% 
CI) 
Multivariate adjusted 
HR *(95% CI)** 
Male   
<6 1.00 1.00 
6-7 1.42 (0.74-2.73) 1.43 (0.75-2.74) 
7-8 0.94 (0.50-1.74) 1.06 (0.57-1.97) 
8-9 0.90 (0.49-1.69) 1.00 (0.53-1.87) 
>9 1.24 (0.68-2.26) 1.00 (0.65-2.22) 
   
Female   
<6 1.00 1.00 
6-7 0.80 (0.30-2.17) 0.74 (0.27-2.02) 
7-8 1.21 (0.52-2.80) 1.05 (0.45-2.45) 
8-9 1.51 (0.67-3.42) 1.15 (0.50-2.68) 
<9 0.86 (0.36-2.10) 0.66 (0.26-1.68) 
Combined   
<6 1.00 1.00 
6-7 1.22 (0.71-2.08) 1.14 (0.67-1.95) 
7-8 1.02 (0.62-1.67) 1.02 (0.62-1.68) 
8-9 1.05 (0.64-1.73) 1.03 (0.62-1.69) 
 23 
<9 1.15 (0.71-1.86) 1.00 (0.61-1.65) 
*Adjusted for age, BMI, smoking, alcohol consumption, medications (aspiring, ACEI, 
beta blockers, anti-platelets, diuretics, and lipid lowering agents), comorbidities (type II 
diabetes, hypertension, and kidney disease). 
**CI= Confidence interval 
 
         
       A third sensitivity analysis was performed using the first SUA value after urate 
lowering therapy (ULT) as the exposure; again this was considered as categorical 
variables. However, the number of new MI cases was small. Of the 3671 male subjects 
included in the analysis 55 subjects experienced an MI. There were 1467 female subjects 
included in this analysis, with 19 new cases of MI. Thus, further analyses to assess the 
association between SUA levels and risk of MI were not performed because the small 
number of events in each SUA categories may have generated unstable effect estimates.  
 In this analysis sample size across SUA levels were small, and in the case of SUA higher 
than 6 mg/dl groups there were only two cases of MI in each group. 
 
 
Table 7. Relationship of SUA after using ULT* and risk of MI 






Crude HR (95% 
CI)*** 
Male     
<6mg/dl 16 6269.34 2.55 1.00 
6-7mg/dl 16 4157.89 3.85 1.90 (0.62-5.84) 
7-8mg/dl 7 3599.20 1.94 1.59 (0.56-4.84) 
8-9mg/dl 12 2433.40 4.93 1.66 (0.59-4.59) 
>9mg/dl 4 2050.37 1.95 1.54 (0.54-4.36) 
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Female     
<6mg/dl 8 3286.68 2.43 1.00 
6-7mg/dl 5 1239.92 4.03 4.69 (0.47-46.24) 
7-8mg/dl 2 995.55 2.01 3.61 (0.37-35.32) 
8-9mg/dl 2 567.69 3.52 6.93 (0.82-58.42) 
>9mg/dl 2 610.01 3.28 3.44 (0.39-30.37) 
*Urate Lowering Therapy 
** Myocardial Infarction 




       This large cohort study of subjects with gout demonstrated that the incidence of MI 
was not associated with SUA levels. This was consistent in the age-adjusted and fully 
adjusted models for both men and women. 
 
  Many studies have examined the relationship between high SUA and risk of 
cardiovascular mortality and morbidity including MI. The findings, however, were 
conflicting.  While several studies have shown that SUA level is associated with an 
increased risk of cardiovascular morbidity and mortality,71-72, 77, 83-84 specifically MI,73-74 
other large cohort studies, such as the Framingham Heart Study, the Atherosclerosis Risk 
in Communities (ARIC) study, and more recently,75-76 some high risk population studies 
(e.g. Type II diabetes, and overweight/obese persons) found no independent association 
between SUA levels and the incidence of CVD, particularly MI. 78-82   
 
The main reasons for these conflicting results include differences among study 
population examine for example, in the gout population whereby different definitions of 
gout are used in each study (i.e. self reported gout, documented diagnosis, documented 
diagnosis +use of anti-gout medications). In addition, some of these studies used a high-
risk study population such as those with previous history of MI, and other CHD 
comorbidities. This high-risk population will have a higher tendency to develop 
subsequent CV events or death.  Furthermore, other studies failed to account for 
cardiovascular risk factors in their analysis, including hypertension, diabetes, high 
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cholesterol, and smoking status. Thus this could bias the results toward the presence of an 
association.  In the current study, the study population was defined using a special gout 
definition (gout diagnosis + anti-gout medication + SUA), and excluded any subject with 
previous MI or other CHD comorbidities; moreover, this study assessed all possible 
potential confounders in the main analysis to get the most pure possible relation between 
SUA and risk of MI among gout.   
 
        In this study, different levels of baseline serum uric acid levels were used in persons 
with gout to assess the effect of SUA on the risk for MI. No association of any kind was 
found whether dependent or independent, and this finding did not change after using the 
fully adjusting model, and sensitivity analysis tests. Recently two studies have reported 
an increase risk of MI among the gout population compared to the non-gout population; 
88,89
 however, neither of these two studies has examined the relation of SUA levels to risk 
of MI, because of unavailability of data on SUA in their database. Their explanation 
based on their findings could suggest that the risk of MI could be mediated through the 
inflammatory process and released mediators when patients experienced an acute gout 
attack.88, 89 SUA could increase the risk of MI through indirect pathways either through 
gout or an increased risk of related cardiovascular risks such as hypertension, diabetes 
type II, high cholesterol.89  
  
Furthermore, Seminog OO et al. did not control for very important potential confounders 
including smoking, hypertension, dyslipidemia, alcohol status, BMI, and medication 
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used. As such, their findings could be a result of not considering these important factors 
in their model. In the current study, all potential confounders were included in main 
analysis including the fully adjusted model to overcome of any unwanted potential effect. 
In addition, current study used SUA levels in gout population to examine relation of SUA 
level and risk of MI. Both approaches further strengthen this study’s finding. 
 
       Stack et al., using the NHANES III dataset, examined SUA levels in relation to 
cardiovascular mortality and all-cause mortality among gout and non-gout subjects. They, 
along with many previous studies, were able to confirm an independent association. In 
this study CV mortality risk was higher with each increase of SUA quartiles; this was 
consistent in both men and women. A similar pattern of association was found between 
SUA quartiles and all-cause mortality.  In addition, they were able to find an association 
when they examined CV mortality, all-cause mortality (i.e. cardiovascular and non-
cardiovascular cause of mortality) with gout. However, the investigators did not assess 
the effect on MI. Cardiovascular mortality could have resulted from some other heart 
conditions. Furthermore, it might be related to the level of health awareness, or presence 
of additional risk factors. For instance, the presence of high serum concentrations of 
inflammatory markers in those with gout disease might have explained the high 






In general there are some explanations for the differences found in the previous findings, 
including: 
1- Different study population characteristics such as male only, women only, or 
including a high-risk population with a history of ischemic heart disease (IHD) or 
previous MI.  
2- Evidence has shown that serum uric acid is associated with CVD risk factors such 
as diabetes, hypertension, and metabolic syndrome. Thus, an association between 
serum uric acid and CVD, particularly MI, is plausible, however, this association 
may not be the direct result of serum uric acid concentrations. This indirect 
mechanism could be mediated through the duration of exposure to serum uric 
acid; the longer the exposure to SUA, the greater the potential to develop an MI. 
Second, this could be mediated through gout (not high serum uric acid levels) via 
the effect of chronic inflammation, 107, 108 or the development of high risk 
conditions (for MI) such as diabetes, hypertension, and obesity.109 
 
Strengths 
This was a large cohort study using a UK representative validated database network. This 
study was able to account for many possible confounders including, comorbidities 
(diabetes type II, hypertension, kidney disease), smoking, alcohol, medication use 
(diuretics, aspirin, ACEI, B-blockers), and obesity.  
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This study was able to exclude subjects with high risk factors including those with 
previous history of ischemic heart disease (IHD) and MI, thus minimizing any carry over 
effect of established IHD.  Finally in the current analysis, the GP’s diagnosis of gout was 
used; specific medications used for the treatment of gout was considered, and SUA 
testing was performed to define gout subjects; thus the gout diagnosis in this study is 
accurate. Such approach has been used in previous studies in THIN as well.  
 
 Limitations 
 Several limitations of the study are worth noting. First, the percentage of missing 
information on several important confounders was relatively high. For example, 
approximately 3.16%, 10.08%, and 11.84 male subjects did not have information on 
smoking, alcohol consumption, and BMI, respectively. Similarly, 1.96%, 8.54%, and 
6.44% and 1.96 female subjects sis not have information on smoking status, alcohol 
consumption, and BMI, respectively. However, when analyses were performed using 
complete-subject approach (i.e. excluded everyone with missing information from the 
analyses), the results did not change significantly. Nevertheless, in the future analysis, 
imputation methods should be considered to predict and fill in the missing values based 







Other potential confounders, such as diet and race were not collected in the THIN dataset. 
These factors may affect the study findings as well. For example, some high-purine 
content foods such as red meat are not only associated with SUA levels, but are also 
related to risk of CHD.110 According to some epidemiological data, certain races have a 
high risk of developing gout and CHD specifically MI, such as African Americans.111, 112, 
113
. However, it is unlikely these factors had any effect on current study’s finding e.g. red 
meat, it is correlated with high SUA level and increase risk of MI, but here high SUA 
level is not associated with increased risk of MI.  
 
Misclassification 
There is the possibility of misclassification between categories such as in the case of 
serum uric acid levels. SUA levels fluctuate over-time as a result of the progress of gout 
disease and/or because of anti-gout medications. In this study, only one serum uric acid 
measurement was available for the majority of subjects (i.e. more than 2/3 of subjects), 
thus some subjects could be misclassified at the time of event (MI) based on their 
baseline serum uric acid level. Furthermore, for those who received urate lowering 
medication, the majority did not have SUA measurement after medication, thus SUA 
groups during follow up period till time to event could have been misclassified. This 
could influence current study’s findings (i.e. overestimate or underestimate relation of 




Serum uric acid 
In this study, only subjects who had at least one baseline SUA measurement were 
included as part of the gout definition. As mentioned above, the majority of subjects had 
only one serum uric acid measurement, thus this study was unable to assess if the change 
in SUA over time predicted MI risk. Furthermore, SUA levels may change over time 
owing to uric lowering therapy. However, such data were not collected in many subjects 
in this study, thus limiting the ability to perform a time-varying exposure analysis.   
 
Future Study Plans  
Based on current study database problems and analysis issues, it would be appropriate to 
consider the following future study designs: 
1- A Meta-analysis including any gout population based study using SUA, MI 
2- Collect data prospectively for subjects diagnosed with gout to include SUA and 
all potential covariates.  
3- Use a different database with as complete information as possible such as diet, 
race, and level of education. To assess the effect of these covariates on SUA and 
risk of MI 
4- A clinical trial to study the effect of urate lowering therapy on serum uric acid 
level and risk of MI. 
5- A clinical trial to determine the effect of treating asymptomatic hyperuricemia on 
risk of MI.   
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Conclusion 
This large retrospective cohort study found that SUA levels assessed at baseline were not 
associated with risk of MI among subjects with gout.   
Next step, to better answer this study question, would be to recommend a long term 
prospective study or use a different database containing more complete information. 
Further research is needed to determine if changes in SUA after uric-lowering therapy is 


















Myocardial Infarction Read Codes and Description 
 
Description Read Code 
Acute transmural myocardial infarction of unspecified site Gyu3400 
Other current complications following acute myocardial 
infarct 
Gyu3100 
Subsequent myocardial infarction of other sites Gyu3500 
Subsequent myocardial infarction of unspecified site Gyu3600 
Acute anteroapical infarction G301000 
Acute anterolateral infarction G300.00 
Acute anteroseptal infarction G301100 
Acute atrial infarction G30y000 
Acute coronary insufficiency G31y000 
Acute coronary syndrome G311500 
Acute inferolateral infarction G302.00 
Acute inferoposterior infarction G303.00 
Acute myocardial infarction G30..00 
Acute myocardial infarction NOS G30z.00 
Acute non-Q wave infarction G307000 
Acute non-ST segment elevation myocardial infarction G307100 
Acute papillary muscle infarction G30y100 
Acute posterolateral myocardial infarction G30B.00 
Acute Q-wave infarct G309.00 
Acute septal infarction G30y200 
Acute ST segment elevation myocardial infarction G30X000 
Acute subendocardial infarction G307.00 
Acute transmural myocardial infarction of unspecified site G30X.00 
Admit ischaemic heart disease emergency 8H2V.00 
Aneurysm of coronary vessels G341200 
Angina at rest G311.14 
Angina at rest G311200 
Angina control 662K.00 
Angina control – good 662K000 
Angina control – improving 662K200 
Angina control – poor 662K100 
Angina control – worsening 662K300 
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Angina control NOS 662Kz00 
Angina decubitus G330.00 
Angina decubitus NOS G330z00 
Angina on effort G33z300 
Angina pectoris G33..00 
Angina pectoris NOS G33z.00 
Angina pectoris NOS G33zz00 
Anterior myocardial infarction NOS G301z00 
Arteriosclerotic heart disease G3...11 
Asymptomatic coronary heart disease G34z000 
Atherosclerotic cardiovascular disease G342.00 
Atherosclerotic heart disease G3...12 
Atrial septal defect/current complication following acute 
myocardial infarction 
G361.00 
Attack – heart G30..11 
Cardiac aneurysm G341.11 
Cardiac rupture following myocardial infarction (MI) G30..13 
Certain current complication follow acute myocardial 
infarct 
G36..00 
Chronic coronary insufficiency G34y000 
Chronic myocardial ischaemia G34y100 
Coronary artery disease G340.12 
Coronary artery spasm G332.00 
Coronary atherosclerosis G340.00 
Coronary thrombosis G30..12 
Coronary thrombosis not resulting in myocardial 
infarction 
G312.00 
Crescendo angina G311.11 
Diabetes  mellitus insulin-glucose infusion acute 
myocardial infarct 
889A.00 
Double coronary vessel disease G340100 
Dressler's syndrome G310.11 
ECG: antero-septal infarct. 3233.00 
ECG: lateral infarction 3236.00 
ECG: myocardial infarct NOS 323Z.00 
ECG: old myocardial infarction 3232.00 
ECG: subendocardial infarct 3235.00 
ECG:posterior/inferior infarct 3234.00 
H/O: myocardial infarct <60 14A3.00 
H/O: myocardial infarct >60 14A4.00 
H/O: Myocardial infarction in last year 14AH.00 
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Haemopericardium/current comp following acute 
myocardial infarct 
G360.00 
Healed myocardial infarction G32..11 
Heart attack G30..14 
History of myocardial infarction 14AT.00 
IHD - Ischaemic heart disease G3...13 
Impending infarction G311.12 
Inferior myocardial infarction NOS G308.00 
Ischaemic cardiomyopathy G343.00 
Ischaemic chest pain G33z400 
Ischaemic heart disease G3...00 
Ischaemic heart disease NOS G3z..00 
Lateral myocardial infarction NOS G305.00 
MI - acute myocardial infarction G30..15 
MI - myocardial infarction aborted G311011 
Microinfarction of heart G31y100 
Mural thrombosis G30A.00 
Myocardial infarction aborted G311000 
New onset angina G33z600 
Nocturnal angina G330000 
Old myocardial infarction G32..00 
Other acute and subacute ischaemic heart disease G31..00 
Other acute and subacute ischaemic heart disease G31y.00 
Other acute and subacute ischaemic heart disease NOS G31yz00 
Other acute myocardial infarction G30y.00 
Other acute myocardial infarction NOS G30yz00 
Other chronic ischaemic heart disease G34..00 
Other chronic ischaemic heart disease NOS G34z.00 
Other specified anterior myocardial infarction G301.00 
Other specified chronic ischaemic heart disease G34y.00 
Other specified chronic ischaemic heart disease NOS G34yz00 
Other specified ischaemic heart disease G3y..00 
Personal history of myocardial infarction G32..12 
Post infarct angina G33z500 
Posterior myocardial infarction NOS G304.00 
Postmyocardial infarction syndrome G310.00 
Postoperative myocardial infarction G38..00 
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Postoperative myocardial infarction, unspecified G38z.00 
Postoperative subendocardial myocardial infarction G384.00 
Postoperative transmural myocardial infarction anterior 
wall 
G380.00 
Postoperative transmural myocardial infarction inferior 
wall 
G381.00 
Postoperative transmural myocardial infarction other sites G382.00 
Postoperative transmural myocardial infarction unspec 
site 
G383.00 
Preinfarction syndrome G311.00 
Preinfarction syndrome NOS G311z00 
Prinzmetal's angina G331.00 
Refractory angina G311300 
Rupture cardiac wall without haemopericard/current 
complication following acute MI 
G363.00 
Rupture chordae tendinae/current complication following 
acute myocardial infarct 
G364.00 
Rupture papillary muscle/current comp following acute 
myocardial infarct 
G365.00 
Silent myocardial infarction G30..17 
Silent myocardial ischaemia G344.00 
Single coronary vessel disease G340000 
Stable angina G33z700 
Status anginosus G33z000 
Stenocardia G33z100 
Subendocardial ischaemia G31y200 
Subsequent myocardial infarction G35..00 
Subsequent myocardial infarction of anterior wall G350.00 
Subsequent myocardial infarction of inferior wall G351.00 
Subsequent myocardial infarction of other sites G353.00 
Subsequent myocardial infarction of unspecified site G35X.00 
Syncope anginosa G33z200 
Thrombosis – coronary G30..16 
Thrombosis atrium,auric append&vent/current 
complication following acute MI 
G366.00 
Transient myocardial ischaemia G31y300 
Triple vessel disease of the heart G340.11 
True posterior myocardial infarction G306.00 
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Unstable angina G311.13 
Unstable angina G311100 
Variant angina pectoris G331.11 
Ventricular septal defect/current complication following 
acute myocardial infarction 
G362.00 
Worsening angina G311400 
 
 
Gout Read Code and Description 
Description Read Code 
Gout C34..00 
H/O: gout 1443.00 
Gout monitoring 669..00 
Gouty arthropathy C340.00 
Gout NOS C34z.00 
Gouty arthritis N023.00 
Gouty tophi of hand C34y500 
Gouty arthritis NOS N023z00 
Gouty tophi of other sites C34y200 
Gout treatment changed 6699.00 
Gouty arthritis of the ankle and foot N023700 
Gout due to impairment of renal function C345.00 
Follow-up gout assessment 6692.00 
Date gout treatment started 6695.00 
Gout monitoring NOS 669Z.00 
Gouty tophi of ear C34y000 
Gouty nephropathy C341.00 
Idiopathic gout C342.00 
Gouty arthritis of the hand N023400 
Drug-induced gout C344.00 
Gouty arthritis of toe N023800 
Joints gout affected 6693.00 
Date of last gout attack 6696.00 
Other specified gouty manifestation NOS C34yz00 
Other specified gouty manifestation C34y.00 
Pre-treatment uric acid level 6694.00 
Date gout treatment stopped 669A.00 
Gouty arthritis of the lower leg N023600 
Gouty iritis C34y300 
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Gouty tophi of heart G557300 
Gouty arthritis of the forearm N023300 
Gout associated problems 6697.00 
Gout drug side effects 6698.00 
Gouty arthritis of the upper arm N023200 
Gouty arthritis of other specified site N023y00 
Other secondary gout Nyu1700 
Gouty neuritis C34y400 
Gouty arthritis of multiple sites N023x00 
Gouty nephropathy unspecified C341000 
Gouty tophi of heart C34y100 
Gouty arthritis of unspecified site N023000 
Gouty nephropathy NOS C341z00 
Lead-induced gout C343.00 
Gouty arthritis of the shoulder region N023100 
Gouty arthritis of the pelvic region and thigh N023500 
Gouty arthrpathy due enzyme defects +other 
inherited disorder CE 
Nyu1C00 
 
Hypertension Read Code and Description 
Benign hypertensive heart disease without CCF G211000 
Secondary malignant renovascular hypertension G240000 
Hypertension secondary to other renal disorders Gyu2100 
Hypertensive diseases Gyu2.00 
Other secondary hypertension Gyu2000 
Antihypertensive therapy 8B26.00 
Attends hypertension monitor. 9OI1.00 
Benign essential hypertension G201.00 
Benign essential hypertension in 
pregnancy/childbearing/puerperum  +p/n 
complication 
L120400 
Benign essential hypertension in pregnancy 
/childbearing/puerpruim -not delivery 
L120300 
Benign hypertensive heart and renal disease G231.00 
Benign hypertensive heart disease G211.00 
Benign hypertensive heart disease NOS G211z00 
Benign hypertensive renal disease G221.00 
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BP - hypertensive disease G2...11 
Cardiomegaly – hypertensive G21z011 
Diastolic hypertension G203.00 
Essential hypertension G20..00 
Essential hypertension NOS G20z.00 
Good hypertension control 6627.00 
H/O: hypertension 14A2.00 
High blood pressure G20..11 
Hypertension heart & renal disease +both 
(congestive) heart and renal fail 
G234.00 
Hypertension monitor 2nd letter 9OI5.00 
Hypertension monitor 3rd letter 9OI6.00 
Hypertension monitor phone invite 9OI8.00 
Hypertension monitor verbal inv. 9OI7.00 
Hypertension monitor.1st letter 9OI4.00 
Hypertension monitoring admin.NOS 9OIZ.00 
Hypertension 9 month review 662P000 
Hypertension annual review 662d.00 
Hypertension clinical management plan 8CR4.00 
Hypertension induced by oral contraceptive pill 6146200 
Hypertension monitoring check done 9OIA.00 
Hypertension monitored 9OIA.11 
Hypertension monitoring 662..12 
Hypertension monitoring 662P.00 
Hypertension monitoring admin. 9OI..00 
Hypertension NOS G20z.11 
Hypertension secondary to drug G24z100 
Hypertension secondary to endocrine disorders G244.00 
Hypertension six month review 662c.00 
Hypertension treatment started 662F.00 
Hypertension treatment stopped 662H.00 
Hypertension treatment refused 8I3N.00 
Hypertension: follow-up default 6629.00 
Hypertensive crisis G672.11 
Hypertensive disease G2...00 
Hypertensive disease NOS G2z..00 
Hypertensive encephalopathy G672.00 
Hypertensive heart and renal disease G23..00 
Hypertensive heart and renal disease NOS G23z.00 
Hypertensive heart and renal disease with renal 
failure 
G233.00 
Hypertensive heart disease G21..00 
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Hypertensive heart disease NOS G21z.00 
Hypertensive heart disease NOS G21zz00 
Hypertensive heart disease NOS with CCF G21z100 
Hypertensive heart disease NOS without CCF G21z000 
Hypertensive heart & renal disease with 
(congestive) heart failure 
G232.00 
Hypertensive renal disease G22..00 
Hypertensive renal disease NOS G22z.00 
Hypertensive renal disease with renal failure G222.00 
Hypertensive retinopathy F421300 
Hypertensive treatment changed 662G.00 
Malignant essential hypertension G200.00 
Malignant hypertensive heart and renal disease G230.00 
Malignant hypertensive heart disease G210.00 
Malignant hypertensive heart disease NOS G210z00 
Malignant hypertensive heart disease with CCF G210100 
Malignant hypertensive heart disease without 
CCF 
G210000 
Malignant hypertensive renal disease G220.00 
Moderate hypertension control 662b.00 
On treatment for hypertension 662O.00 
Other pre-exist hypertension in 
pregnancy/childbearing/puerprum  + p/n 
complication 
L122400 
Other pre-exist hypertension in 
pregnancy/childbearing/puerprum -not delivery 
L122300 
Other pre-existing hypertension in 
pregnancy/childbearing/puerprum – delivery 
L122100 
Other pre-existing hypertension in 
pregnancy/childbearing/puerprium NOS 
L122z00 
Other pre-existing hypertension in 
pregnancy/childbirth/puerp unspecified 
L122000 
Patient on maximal tolerated antihypertensive 
therapy 
8BL0.00 
Poor hypertension control 6628.00 
Pre-eclampsia or eclampsia + pre-existing 
hypertension NOS 
L127z00 
Pre-exist hypertension heart disease 
complication pregnancy childbirth + 
puerperium 
L128000 




Pre-exist hypertension complication pregnancy 
childbirth and puerperium 
L128.00 
Referral to hypertension clinic 8HT5.00 
Renal hypertension G22z.11 
Renal hypertension in 
pregnancy/childbirth/puerperium + p/n 
complication 
L121400 
Renal hypertension in 
pregnancy/childbirth/puerprium  -delivery with 
p/n complication 
L121200 
Secondary benign hypertension G241.00 
Secondary benign hypertension NOS G241z00 
Secondary benign renovascular hypertension G241000 
Secondary hypertension G24..00 
Secondary hypertension NOS G24z.00 
Secondary hypertension NOS G24zz00 
Secondary malignant hypertension G240.00 
Secondary malignant hypertension NOS G240z00 
Secondary renovascular hypertension NOS G24z000 
Seen in hypertension clinic 9N03.00 
Seen in hypertension clinic 9N1y200 
Systolic hypertension G202.00 
White coat hypertension 246M.00 
Benign hypertensive heart disease with CCF G211100 
Blind hypertensive eye F404200 
Nephrosclerosis G22..11 
Other pre-existing hypertension in 
pregnancy/childbirth/puerperium 
L122.00 
Other specified hypertensive disease G2y..00 
Pre-exist 2ndry hypertension comp pregnancey 
childbirth and puerperium 
L128200 
 
Kidney Disease Read Code and Description 
Description Read Code 
H/O: kidney recipient 14S2.00 
H/O: renal dialysis 14V2.00 
H/O: kidney dialysis 14V2.11 
Chronic kidney disease stage 3 1Z12.00 
Chronic kidney disease stage 4 1Z13.00 
Chronic kidney disease stage 5 1Z14.00 
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Chronic kidney disease stage 3A 1Z15.00 
Chronic kidney disease stage 3B 1Z16.00 
Chronic kidney disease stage 1 with proteinuria 1Z17.00 
CKD stage 1 with proteinuria 1Z17.11 
Chronic kidney disease stage 2 with proteinuria 1Z19.00 
CKD stage 2 with proteinuria 1Z19.11 
Chronic kidney disease stage 3 with proteinuria 1Z1B.00 
CKD stage 3 with proteinuria 1Z1B.11 
Chronic kidney disease stage 3A with 
proteinuria 
1Z1D.00 
CKD stage 3A with proteinuria 1Z1D.11 
CKD stage 3A without proteinuria 1Z1E.11 
Chronic kidney disease stage 3B with 
proteinuria 
1Z1F.00 
CKD stage 3B with proteinuria 1Z1F.11 
Chronic kidney disease stage 3B without 
proteinuria 
1Z1G.00 
CKD stage 3B without proteinuria 1Z1G.11 
Chronic kidney disease stage 4 with proteinuria 1Z1H.00 
CKD stage 4 with proteinuria 1Z1H.11 
Chronic kidney disease stage 4 without 
proteinuria 
1Z1J.00 
CKD stage 4 without proteinuria 1Z1J.11 
Chronic kidney disease stage 5 with proteinuria 1Z1K.00 
CKD stage 5 with proteinuria 1Z1K.11 
Chronic kidney disease stage 5 without 
proteinuria 
1Z1L.00 
CKD stage 5 without proteinuria 1Z1L.11 
Creation of graft fistula for dialysis 7A60600 
Ligation of arteriovenous dialysis fistula 7A61900 
Ligation of arteriovenous dialysis graft 7A61A00 
Transplantation of kidney 7B00.00 
Autotransplant of kidney 7B00000 
Transplantation of kidney from live donor 7B00100 
Allotransplantation of kidney from live donor 7B00111 
Transplantation of kidney from cadaver 7B00200 
Allotransplantation of kidney from cadaver 7B00211 
Allotransplantation of kidney from cadaver, 
heart-beating 
7B00300 




Allotransplantation of kidney from cadaver 
NEC 
7B00500 
Other specified transplantation of kidney 7B00y00 
Transplantation of kidney NOS 7B00z00 
Dialysis for renal failure 7L1A.11 
Renal dialysis 7L1A000 
Thomas intravascular shunt for dialysis 7L1A011 
Peritoneal dialysis 7L1A100 
Haemodialysis NEC 7L1A200 
Automated peritoneal dialysis 7L1A400 
Continuous ambulatory peritoneal dialysis 7L1A500 
Peritoneal dialysis NEC 7L1A600 
Placement ambulatory dialysis apparatus - 
compensatory renal failure 
7L1B.11 
Insertion of ambulatory peritoneal dialysis 
catheter 
7L1B000 
Removal of ambulatory peritoneal dialysis 
catheter 
7L1B100 
Flushing of peritoneal dialysis catheter 7L1B200 
Extracorporeal albumin haemodialysis 7L1f000 
Chronic glomerulonephritis K02..00 
Nephritis – chronic K02..11 
Nephropathy – chronic K02..12 
Chronic proliferative glomerulonephritis K020.00 




Chronic rapidly progressive glomerulonephritis K023.00 
Other chronic glomerulonephritis K02y.00 
Chronic glomerulonephritis + diseases EC K02y000 
Chronic exudative glomerulonephritis K02y100 
Chronic focal glomerulonephritis K02y200 
Chronic diffuse glomerulonephritis K02y300 
Other chronic glomerulonephritis NOS K02yz00 
Chronic glomerulonephritis NOS K02z.00 
Chronic renal failure K05..00 
Chronic uraemia K05..11 
End stage renal failure K05..12 
Chronic kidney disease K05..13 
End stage renal failure K050.00 
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Chronic kidney disease stage 3 K053.00 
Chronic kidney disease stage 4 K054.00 
Chronic kidney disease stage 5 K055.00 
Renal impairment K060.00 
Impaired renal function K060.11 
Chronic nephritic syndrome K0A3.00 
Chronic nephritic syndrome, minor glomerular 
abnormality 
K0A3000 
Chronic nephritic syndrome focal + segmental 
glomerular lesions 
K0A3100 
Chronic nephritic syndrome diffuse 
membranous glomerulonephritis 
K0A3200 
Chronic nephritic syndrome diffuse mesangial 
proliferative glomerulonephritis 
K0A3300 
Chronic nephritic syndrome diffuse endocap 
proliferative glomerulonephritis 
K0A3400 
Chronic nephritic syndrome diffuse 
mesangiocapillary glomerulonephritis 
K0A3500 
Chronic nephritic syndrome, dense deposit 
disease 
K0A3600 
Chronic nephritic syndrome diffuse crescentric 
glomerulonephritis 
K0A3700 
End-stage renal disease K0D..00 
Acute-on-chronic renal failure K0E..00 
Mechanical complication of dialysis catheter SP01500 
Peritoneal dialysis associated peritonitis SP05613 
Continuous ambulatory peritoneal dialysis 
associated peritonitis 
SP06B00 
Stenosis of arteriovenous dialysis fistula SP07G00 
Deterioration renal function after renal 
transplant 
SP08011 
Kidney transplant failure and rejection SP08300 
Accelerated rejection of renal transplant SP08C00 
Acute-on-chronic rejection of renal transplant SP08D00 
Acute rejection of renal transplant - grade I SP08E00 
Acute rejection of renal transplant - grade II SP08F00 
Acute rejection of renal transplant - grade III SP08G00 
Acute rejection of renal transplant SP08H00 
Acute hypercalcaemia of dialysis SP3y900 




Kidney dialysis with complication, without 
blame 
TB11.00 
Renal dialysis with complication, without 
blame 
TB11.11 
Kidney transplanted ZV42000 
 
Diabetes Description and Read Code 
Description Read Code 
Gangrene of toe in diabetic R054200 
Widespread diabetic foot gangrene R054300 
Diabetes mellitus Cyu2.00 
Glomerular disorders in diabetes mellitus Kyu0300 
Other specified diabetes mellitus Cyu2000 
Pre-existing diabetes mellitus, unspecified Lyu2900 
Unspecified diabetes mellitus with renal 
complications 
Cyu2300 
Acute painful diabetic neuropathy F372000 
Admit diabetic emergency 8H2J.00 
Advanced diabetic maculopathy F420300 
Advanced diabetic retinal disease F420500 
Asymptomatic diabetic neuropathy F372200 
Attending diabetes clinic 9NM0.00 
Attends diabetes monitoring 9OL1.00 
Autonomic neuropathy due to diabetes F171100 
Background diabetic retinopathy F420000 
Brittle diabetes 66AJ100 
Cellulitis in diabetic foot M037200 
Chronic painful diabetic neuropathy F372100 
Date diabetic treatment start 66AN.00 
Diab mellit insulin-glucose infus acute 
myocardial infarct 
889A.00 
Diabetes care by hospital only 66AU.00 
Diabetes care plan agreed 8CS0.00 
Diabetes clinical management plan 8CR2.00 
Diabetes management plan given 66AR.00 
Diabetes medication review 8B3l.00 
Diabetes mellitus C10..00 
Diabetes mellitus autosomal dominant C10C.00 
Diabetes mellitus autosomal dominant type 2 C10D.00 
Diabetes mellitus induced by non-steroid drugs C10H.00 
Diabetes mellitus induced by steroids C10B.00 
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Diabetes mellitus NOS with hyperosmolar 
coma 
C102z00 
Diabetes mellitus NOS with ketoacidosis C101z00 
Diabetes mellitus NOS with ketoacidotic coma C103z00 
Diabetes mellitus NOS with neurological 
manifestation 
C106z00 
Diabetes mellitus NOS with no mention of 
complication 
C100z00 
Diabetes mellitus NOS with ophthalmic 
manifestation 
C105z00 
Diabetes mellitus NOS with other specified 
manifestation 
C10yz00 
Diabetes mellitus NOS with peripheral 
circulatory disorder 
C107z00 
Diabetes mellitus NOS with unspecified 
complication 
C10zz00 
Diabetes mellitus with gangrene C107.11 
Diabetes mellitus with hyperosmolar coma C102.00 
Diabetes mellitus with ketoacidosis C101.00 
Diabetes mellitus with ketoacidotic coma C103.00 
Diabetes mellitus with nephropathy NOS C104z00 
Diabetes mellitus with neurological 
manifestation 
C106.00 
Diabetes mellitus with neuropathy C106.12 
Diabetes mellitus with no mention of 
complication 
C100.00 
Diabetes mellitus with ophthalmic 
manifestation 
C105.00 
Diabetes mellitus with other specified 
manifestation 
C10y.00 
Diabetes mellitus with peripheral circulatory 
disorder 
C107.00 
Diabetes mellitus with polyneuropathy C106.13 
Diabetes mellitus with renal manifestation C104.00 
Diabetes mellitus with unspecified complication C10z.00 
Diabetes mellitus, adult onset, + neurological 
manifestation 
C106100 
Diabetes mellitus, adult onset, + ophthalmic 
manifestation 
C105100 
Diabetes mellitus, adult onset, + unspecified 
complication 
C10z100 
Diabetes mellitus, adult onset, no mention of C100100 
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complication 
Diabetes mellitus, adult onset, with 
hyperosmolar coma 
C102100 
Diabetes mellitus, adult onset, with ketoacidosis C101100 
Diabetes mellitus, adult onset, with ketoacidotic 
coma 
C103100 
Diabetes mellitus, adult onset, with renal 
manifestation 
C104100 
Diabetes mellitus, adult with gangrene C107200 
Diabetes mellitus, adult, + other specified 
manifestation 
C10y100 
Diabetes mellitus, adult, + peripheral 
circulatory disorder 
C107100 
Diabetes mellitus, juvenile +peripheral 
circulatory disorder 
C107000 
Diabetes mellitus, juvenile type, + ophthalmic 
manifestation 
C105000 
Diabetes mellitus, juvenile type, + unspecified 
complication 
C10z000 
Diabetes mellitus, juvenile type, no mention of 
complication 
C100000 
Diabetes mellitus, juvenile type, with 
hyperosmolar coma 
C102000 
Diabetes mellitus, juvenile type, with 
ketoacidosis 
C101000 
Diabetes mellitus, juvenile type, with 
ketoacidotic coma 
C103000 
Diabetes mellitus, juvenile type, with renal 
manifestation 
C104000 
Diabetes mellitus, juvenile, + neurological 
manifestation 
C106000 
Diabetes mellitus, juvenile, + other specified 
manifestation 
C10y000 
Diabetes monitor. check done 9OLA.00 
Diabetes monitored 9OLA.11 
Diabetes monitoring 2nd letter 9OL5.00 
Diabetes monitoring admin. 9OL..00 
Diabetes monitoring default 9OL3.00 
Diabetes self-management plan agreed 661M400 
Diabetes structured education programme 
declined 
9OLM.00 
Diabetes type 1 review 66An.00 
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Diabetes type 2 review 66Ao.00 
Diabetes with gangrene C107.12 
Diabetes: practice programme 66AP.00 
Diabetes: shared care programme 66AQ.00 
Diabetic - cooperative patient 66AK.00 
Diabetic - follow-up default 66AM.00 
Diabetic - good control 66AI.00 
Diabetic - poor control 66AJ.00 
Diabetic - poor control NOS 66AJz00 
Diabetic 6 month review 66Ai.00 
Diabetic amyotrophy F381311 
Diabetic amyotrophy C106.11 
Diabetic annual review 66AS.00 
Diabetic assessment of erectile dysfunction 66Av.00 
Diabetic cataract F464000 
Diabetic Charcot arthropathy N030100 
Diabetic cheiroarthropathy N030000 
Diabetic cheiropathy N030011 
Diabetic crisis monitoring 8A12.00 
Diabetic diet - good compliance 66AY.00 
Diabetic digital retinopathy screening offered 68AB.00 
Diabetic erectile dysfunction review 66Au.00 
Diabetic foot examination 66Ab.00 
Diabetic foot examination declined 8I3W.00 
Diabetic foot risk assessment 66AW.00 
Diabetic foot screen 66Aq.00 
Diabetic iritis F440700 
Diabetic maculopathy F420400 
Diabetic monitoring 66A..00 
Diabetic monitoring NOS 66AZ.00 
Diabetic mononeuritis multiplex F345000 
Diabetic mononeuritis NOS F35z000 
Diabetic mononeuropathy F3y0.00 
Diabetic nephropathy C104.11 
Diabetic neuropathy F372.12 
Diabetic on diet only 66A3.00 
Diabetic on insulin 66A5.00 
Diabetic on insulin and oral treatment 66AV.00 
Diabetic on oral treatment 66A4.00 
Diabetic on subcutaneous treatment 66As.00 




Diabetic peripheral angiopathy G73y000 
Diabetic peripheral neuropathy screening 66Ac.00 
Diabetic polyneuropathy F372.11 
Diabetic retinopathy F420.00 
Diabetic retinopathy 12 month review 8HBG.00 
Diabetic retinopathy 6 month review 8HBH.00 
Diabetic retinopathy NOS F420z00 
Diabetic retinopathy screening 68A7.00 
Diabetic retinopathy screening offered 68A9.00 
Diabetic retinopathy screening refused 8I3X.00 
Diabetic stabilization 8A13.00 
Diabetic treatment changed 66AH.00 
Diabetic-uncooperative patient 66AL.00 
DM induced by non-steroid drugs without 
complication 
C10H000 
Excepted from diabetes qual indicators: Patient 
unsuitable 
9h41.00 
Excepted from diabetes quality indicators: 
Informed dissent 
9h42.00 
Follow-up diabetic assessment 66A2.00 
Foot abnormality - diabetes related 2G5C.00 
Foot abnormality - diabetes related 2G51000 
Fundoscopy - diabetic check 66AD.00 
H/O: Admission in last year for diabetes foot 
problem 
14F4.00 
H/O: diabetes mellitus 1434.00 
Has seen dietician – diabetes 66A8.00 
Hb. A1C - diabetic control 42W..00 
HbA1 - diabetic control 42c..00 
Health education – diabetes 679L.00 
High risk non proliferative diabetic retinopathy F420800 
High risk proliferative diabetic retinopathy F420700 
Hyperosmolar non-ketotic state in type 2 
diabetes mellitus 
C10FK00 
Hyperosmolar non-ketotic state in type 2 
diabetes mellitus 
C109K00 
Hyperosmolar non-ketotic state in type II 
diabetes mellitus 
C10FK11 
IDDM with peripheral circulatory disorder C107300 
IDDM-Insulin dependent diabetes mellitus C108.11 
Impair vision due diab retinop 2BBr.00 
Initial diabetic assessment 66A1.00 
Injection sites – diabetic 66AA.11 
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Insulin dependent diab mell with neuropathic 
arthropathy 
C108J00 
Insulin dependent diab mell with neuropathic 
arthropathy 
C10EJ12 
Insulin dependent diab mell with peripheral 
angiopathy 
C108G00 
Insulin dependent diab mell with peripheral 
angiopathy 
C10EG12 
Insulin dependent diabetes maturity onset C108900 
Insulin dependent diabetes maturity onset C10E912 
Insulin dependent diabetes mellitus C100011 
Insulin dependent diabetes mellitus C108.00 
Insulin dependent diabetes mellitus C10E.12 
Insulin dependent diabetes mellitus - poor 
control 
C108800 
Insulin dependent diabetes mellitus - poor 
control 
C10E812 
Insulin dependent diabetes mellitus with 
arthropathy 
C108H00 
Insulin dependent diabetes mellitus with 
arthropathy 
C10EH12 
Insulin dependent diabetes mellitus with 
diabetic cataract 
C108F00 
Insulin dependent diabetes mellitus with 
diabetic cataract 
C10EF12 
Insulin dependent diabetes mellitus with 
gangrene 
C108600 
Insulin dependent diabetes mellitus with 
gangrene 
C10E612 
Insulin dependent diabetes mellitus with 
hypoglycaemic coma 
C108E00 
Insulin dependent diabetes mellitus with 
hypoglycaemic coma 
C10EE12 
Insulin dependent diabetes mellitus with 
mononeuropathy 
C108B00 
Insulin dependent diabetes mellitus with 
mononeuropathy 
C10EB12 
Insulin dependent diabetes mellitus with 
multiple complicat 
C10E312 
Insulin dependent diabetes mellitus with 
multiple complicatn 
C108300 




Insulin dependent diabetes mellitus with 
nephropathy 
C10ED12 
Insulin dependent diabetes mellitus with 
polyneuropathy 
C108C00 
Insulin dependent diabetes mellitus with 
polyneuropathy 
C10EC12 
Insulin dependent diabetes mellitus with 
retinopathy 
C108700 
Insulin dependent diabetes mellitus with 
retinopathy 
C10E712 
Insulin dependent diabetes mellitus with ulcer C108500 
Insulin dependent diabetes mellitus with ulcer C10E512 
Insulin treated non-insulin dependent diabetes 
mellitus 
C109J11 
Insulin treated Type 2 diabetes mellitus C10FJ00 
Insulin treated Type 2 diabetes mellitus C109J00 
Insulin treated Type II diabetes mellitus C10FJ11 
Insulin treated Type II diabetes mellitus C109J12 
Insulin-dependent diabetes mellitus with 
neurological comps 
C108200 
Insulin-dependent diabetes mellitus with 
neurological comps 
C10E212 
Insulin-dependent diabetes mellitus with 
ophthalmic comps 
C108100 
Insulin-dependent diabetes mellitus with 
ophthalmic comps 
C10E112 
Insulin-dependent diabetes mellitus with renal 
complications 
C108000 
Insulin-dependent diabetes mellitus with renal 
complications 
C10E012 
Insulin-dependent diabetes without 
complication 
C108A00 
Insulin-dependent diabetes without 
complication 
C10EA12 
Ischaemic ulcer diabetic foot M271000 
Latent autoimmune diabetes mellitus in adult C10ER00 
Maternally inherited diabetes mellitus C10FS00 
Maturity onset diabetes C100111 
Maturity onset diabetes in youth C10C.11 
Maturity onset diabetes in youth type 1 C10C.12 
Maturity onset diabetes in youth type 2 C10D.11 
Mixed diabetic ulcer – foot M271200 
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Myasthenic syndrome due to diabetic 
amyotrophy 
F381300 
Nephrotic syndrome in diabetes mellitus K01x100 
Neuropathic diabetic ulcer – foot M271100 
NIDDM - Non-insulin dependent diabetes 
mellitus 
C109.11 
NIDDM with peripheral circulatory disorder C107400 
Non proliferative diabetic retinopathy F420600 
Non-insulin depend diabetes mellitus with 
diabetic cataract 
C109E00 
Non-insulin dependent d m with neuropathic 
arthropathy 
C109H00 
Non-insulin dependent diabetes mellitus C109.00 
Non-insulin dependent diabetes mellitus C100112 
Non-insulin dependent diabetes mellitus - poor 
control 
C109700 
Non-insulin dependent diabetes mellitus with 
arthropathy 
C109G00 
Non-insulin dependent diabetes mellitus with 
gangrene 
C109500 
Non-insulin dependent diabetes mellitus with 
hypoglyca coma 
C109D00 
Non-insulin dependent diabetes mellitus with 
mononeuropathy 
C109A00 
Non-insulin dependent diabetes mellitus with 
nephropathy 
C109C00 
Non-insulin dependent diabetes mellitus with 
polyneuropathy 
C109B00 
Non-insulin dependent diabetes mellitus with 
ulcer 
C109400 
Non-insulin-dependent d m with peripheral 
angiopath 
C109F00 
Non-insulin-dependent diabetes mellitus with 
multiple comps 
C109300 
Non-insulin-dependent diabetes mellitus with 
neuro comps 
C109200 
Non-insulin-dependent diabetes mellitus with 
ophthalm comps 
C109100 
Non-insulin-dependent diabetes mellitus with 
renal comps 
C109000 




Non-insulin-dependent diabetes mellitus 
without complication 
C109900 
Non-urgent diabetic admission 8H3O.00 
O/E - diabetic maculopathy present both eyes 2BBL.00 
O/E - left chronic diabetic foot ulcer 2G5W.00 
O/E - Left diabetic foot – ulcerated 2G5L.00 
O/E - Left diabetic foot at high risk 2G5K.00 
O/E - Left diabetic foot at low risk 2G5I.00 
O/E - Left diabetic foot at moderate risk 2G5J.00 
O/E - Left diabetic foot at risk 2G5B.00 
O/E - left eye background diabetic retinopathy 2BBQ.00 
O/E - left eye diabetic maculopathy 2BBX.00 
O/E - left eye preproliferative diabetic 
retinopathy 
2BBS.00 
O/E - left eye proliferative diabetic retinopathy 2BBV.00 
O/E - left eye stable treated prolif diabetic 
retinopathy 
2BBl.00 
O/E - right chronic diabetic foot ulcer 2G5V.00 
O/E - Right diabetic foot – ulcerated 2G5H.00 
O/E - Right diabetic foot at high risk 2G5G.00 
O/E - Right diabetic foot at low risk 2G5E.00 
O/E - Right diabetic foot at moderate risk 2G5F.00 
O/E - Right diabetic foot at risk 2G5A.00 
O/E - right eye background diabetic retinopathy 2BBP.00 
O/E - right eye diabetic maculopathy 2BBW.00 
O/E - right eye preproliferative diabetic 
retinopathy 
2BBR.00 
O/E - right eye proliferative diabetic 
retinopathy 
2BBT.00 
O/E - right eye stable treated prolif diabetic 
retinopathy 
2BBk.00 
O/E - sight threatening diabetic retinopathy 2BBo.00 
Other specified diabetes mellitus with coma C103y00 
Other specified diabetes mellitus with 
ketoacidosis 
C101y00 
Other specified diabetes mellitus with multiple 
comps 
C108y00 
Other specified diabetes mellitus with 
neurological comps 
C106y00 




Other specified diabetes mellitus with other 
spec comps 
C10yy00 
Other specified diabetes mellitus with periph 
circ comps 
C107y00 
Other specified diabetes mellitus with renal 
complications 
C104y00 
Other specified diabetes mellitus with 
unspecified comps 
C10zy00 
Pan retinal photocoagulation for diabetes 7276.00 
Patient diabetes education review 66Af.00 
Patient on maximal tolerated therapy for 
diabetes 
8BL2.00 
Perceived control of insulin-dependent diabetes ZRbH.00 
Polyneuropathy in diabetes F372.00 
Pre-existing diabetes mellitus, insulin-
dependent 
L180500 
Pre-existing diabetes mellitus, non-insulin-
dependent 
L180600 
Pre-existing diabetes mellitus, unspecified L180X00 
Preproliferative diabetic retinopathy F420200 
Private referral to diabetologist 8HVU.00 
Proliferative diabetic retinopathy F420100 
Refer to diabetic foot screener 8H7r.00 
Refer, diabetic liaison nurse 8H7C.00 
Referral for diabetic retinopathy screening 8Hl1.00 
Referral to community diabetes specialist nurse 8Hl4.00 
Referral to diabetes nurse 8H7f.00 
Referral to diabetes nurse ZL62500 
Referral to diabetes special interest general 
practitioner 
8H4e.00 
Referral to diabetes structured education 
programme 
8Hj0.00 
Referral to diabetic eye clinic 8HTk.00 
Referral to diabetic liaison nurse ZL62600 
Referral to diabetologist 8H4F.00 
Referral to multidisciplinary diabetic clinic 8HTi.00 
Referral to XPERT diabetes structured 
education programme 
8Hj5.00 
Retinal abnormality - diabetes related 2BBF.00 
Seen by diabetic liaison nurse 9N2i.00 
Seen in community diabetes specialist clinic 9N0n.00 
Seen in community diabetic specialist nurse 9N0o.00 
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clinic 
Seen in diabetic clinic 9N1Q.00 
Seen in diabetic eye clinic 9N1v.00 
Seen in diabetic foot clinic 9N1i.00 
Steroid induced diabetes C11y000 
Steroid induced diabetes mellitus without 
complication 
C10B000 
Type 1 diabetes mellitus C10E.00 
Type 1 diabetes mellitus C108.12 
Type 1 diabetes mellitus - poor control C10E800 
Type 1 diabetes mellitus - poor control C108812 
Type 1 diabetes mellitus maturity onset C10E900 
Type 1 diabetes mellitus maturity onset C108912 
Type 1 diabetes mellitus with arthropathy C10EH00 
Type 1 diabetes mellitus with arthropathy C108H12 
Type 1 diabetes mellitus with diabetic cataract C10EF00 
Type 1 diabetes mellitus with diabetic cataract C108F12 
Type 1 diabetes mellitus with exudative 
maculopathy 
C10EP00 
Type 1 diabetes mellitus with gangrene C10E600 
Type 1 diabetes mellitus with gangrene C108612 
Type 1 diabetes mellitus with gastroparesis C10EQ00 
Type 1 diabetes mellitus with hypoglycaemic 
coma 
C10EE00 
Type 1 diabetes mellitus with hypoglycaemic 
coma 
C108E12 
Type 1 diabetes mellitus with ketoacidosis C10EM00 
Type 1 diabetes mellitus with ketoacidotic 
coma 
C10EN00 
Type 1 diabetes mellitus with mononeuropathy C10EB00 
Type 1 diabetes mellitus with mononeuropathy C108B12 
Type 1 diabetes mellitus with multiple 
complications 
C10E300 
Type 1 diabetes mellitus with multiple 
complications 
C108312 
Type 1 diabetes mellitus with nephropathy C10ED00 
Type 1 diabetes mellitus with nephropathy C108D12 
Type 1 diabetes mellitus with neurological 
complications 
C10E200 




Type 1 diabetes mellitus with neuropathic 
arthropathy 
C10EJ00 
Type 1 diabetes mellitus with neuropathic 
arthropathy 
C108J12 
Type 1 diabetes mellitus with ophthalmic 
complications 
C10E100 
Type 1 diabetes mellitus with ophthalmic 
complications 
C108112 
Type 1 diabetes mellitus with peripheral 
angiopathy 
C108G12 
Type 1 diabetes mellitus with peripheral 
angiopathy 
C10EG00 
Type 1 diabetes mellitus with persistent 
microalbuminuria 
C10EL00 
Type 1 diabetes mellitus with persistent 
proteinuria 
C10EK00 
Type 1 diabetes mellitus with polyneuropathy C10EC00 
Type 1 diabetes mellitus with polyneuropathy C108C12 
Type 1 diabetes mellitus with renal 
complications 
C10E000 
Type 1 diabetes mellitus with renal 
complications 
C108012 
Type 1 diabetes mellitus with retinopathy C10E700 
Type 1 diabetes mellitus with retinopathy C108712 
Type 1 diabetes mellitus with ulcer C10E500 
Type 1 diabetes mellitus with ulcer C108512 
Type 1 diabetes mellitus without complication C10EA00 
Type 1 diabetes mellitus without complication C108A12 
Type 2 diabetes mellitus C10F.00 
Type 2 diabetes mellitus C109.12 
Type 2 diabetes mellitus - poor control C10F700 
Type 2 diabetes mellitus - poor control C109712 
Type 2 diabetes mellitus with arthropathy C10FG00 
Type 2 diabetes mellitus with arthropathy C109G12 
Type 2 diabetes mellitus with diabetic cataract C10FE00 
Type 2 diabetes mellitus with diabetic cataract C109E12 
Type 2 diabetes mellitus with exudative 
maculopathy 
C10FQ00 
Type 2 diabetes mellitus with gangrene C10F500 
Type 2 diabetes mellitus with gangrene C109512 
Type 2 diabetes mellitus with gastroparesis C10FR00 
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Type 2 diabetes mellitus with hypoglycaemic 
coma 
C10FD00 
Type 2 diabetes mellitus with hypoglycaemic 
coma 
C109D12 
Type 2 diabetes mellitus with ketoacidosis C10FN00 
Type 2 diabetes mellitus with ketoacidotic 
coma 
C10FP00 
Type 2 diabetes mellitus with mononeuropathy C10FA00 
Type 2 diabetes mellitus with mononeuropathy C109A12 
Type 2 diabetes mellitus with multiple 
complications 
C10F300 
Type 2 diabetes mellitus with multiple 
complications 
C109312 
Type 2 diabetes mellitus with nephropathy C10FC00 
Type 2 diabetes mellitus with nephropathy C109C12 
Type 2 diabetes mellitus with neurological 
complications 
C10F200 
Type 2 diabetes mellitus with neurological 
complications 
C109212 
Type 2 diabetes mellitus with neuropathic 
arthropathy 
C10FH00 
Type 2 diabetes mellitus with neuropathic 
arthropathy 
C109H12 
Type 2 diabetes mellitus with ophthalmic 
complications 
C10F100 
Type 2 diabetes mellitus with ophthalmic 
complications 
C109112 
Type 2 diabetes mellitus with peripheral 
angiopathy 
C10FF00 
Type 2 diabetes mellitus with peripheral 
angiopathy 
C109F12 
Type 2 diabetes mellitus with persistent 
microalbuminuria 
C10FM00 
Type 2 diabetes mellitus with persistent 
proteinuria 
C10FL00 
Type 2 diabetes mellitus with polyneuropathy C10FB00 
Type 2 diabetes mellitus with polyneuropathy C109B12 
Type 2 diabetes mellitus with renal 
complications 
C10F000 
Type 2 diabetes mellitus with renal 
complications 
C109012 
Type 2 diabetes mellitus with retinopathy C10F600 
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Type 2 diabetes mellitus with retinopathy C109612 
Type 2 diabetes mellitus with ulcer C10F400 
Type 2 diabetes mellitus with ulcer C109412 
Type 2 diabetes mellitus without complication C10F900 
Type 2 diabetes mellitus without complication C109912 
Type I diabetes mellitus C108.13 
Type I diabetes mellitus C10E.11 
Type I diabetes mellitus - poor control C108811 
Type I diabetes mellitus - poor control C10E811 
Type I diabetes mellitus maturity onset C10E911 
Type I diabetes mellitus maturity onset C108911 
Type I diabetes mellitus with arthropathy C108H11 
Type I diabetes mellitus with arthropathy C10EH11 
Type I diabetes mellitus with diabetic cataract C108F11 
Type I diabetes mellitus with diabetic cataract C10EF11 
Type I diabetes mellitus with exudative 
maculopathy 
C10EP11 
Type I diabetes mellitus with gangrene C10E611 
Type I diabetes mellitus with gangrene C108611 
Type I diabetes mellitus with gastroparesis C10EQ11 
Type I diabetes mellitus with hypoglycaemic 
coma 
C108E11 
Type I diabetes mellitus with hypoglycaemic 
coma 
C10EE11 
Type I diabetes mellitus with ketoacidosis C10EM11 
Type I diabetes mellitus with ketoacidotic coma C10EN11 
Type I diabetes mellitus with mononeuropathy C108B11 
Type I diabetes mellitus with mononeuropathy C10EB11 
Type I diabetes mellitus with multiple 
complications 
C10E311 
Type I diabetes mellitus with multiple 
complications 
C108311 
Type I diabetes mellitus with nephropathy C108D11 
Type I diabetes mellitus with nephropathy C10ED11 
Type I diabetes mellitus with neurological 
complications 
C108211 
Type I diabetes mellitus with neurological 
complications 
C10E211 




Type I diabetes mellitus with neuropathic 
arthropathy 
C10EJ11 
Type I diabetes mellitus with ophthalmic 
complications 
C108111 
Type I diabetes mellitus with ophthalmic 
complications 
C10E111 
Type I diabetes mellitus with peripheral 
angiopathy 
C108G11 
Type I diabetes mellitus with peripheral 
angiopathy 
C10EG11 
Type I diabetes mellitus with persistent 
microalbuminuria 
C10EL11 
Type I diabetes mellitus with persistent 
proteinuria 
C10EK11 
Type I diabetes mellitus with polyneuropathy C108C11 
Type I diabetes mellitus with polyneuropathy C10EC11 
Type I diabetes mellitus with renal 
complications 
C108011 
Type I diabetes mellitus with renal 
complications 
C10E011 
Type I diabetes mellitus with retinopathy C108711 
Type I diabetes mellitus with retinopathy C10E711 
Type I diabetes mellitus with ulcer C108511 
Type I diabetes mellitus with ulcer C10E511 
Type I diabetes mellitus without complication C10EA11 
Type I diabetes mellitus without complication C108A11 
Type II diabetes mellitus C109.13 
Type II diabetes mellitus C10F.11 
Type II diabetes mellitus - poor control C10F711 
Type II diabetes mellitus - poor control C109711 
Type II diabetes mellitus with arthropathy C10FG11 
Type II diabetes mellitus with arthropathy C109G11 
Type II diabetes mellitus with diabetic cataract C109E11 
Type II diabetes mellitus with diabetic cataract C10FE11 
Type II diabetes mellitus with exudative 
maculopathy 
C10FQ11 
Type II diabetes mellitus with gangrene C109511 
Type II diabetes mellitus with gangrene C10F511 
Type II diabetes mellitus with gastroparesis C10FR11 




Type II diabetes mellitus with hypoglycaemic 
coma 
C10FD11 
Type II diabetes mellitus with ketoacidosis C10FN11 
Type II diabetes mellitus with ketoacidotic 
coma 
C10FP11 
Type II diabetes mellitus with mononeuropathy C10FA11 
Type II diabetes mellitus with mononeuropathy C109A11 
Type II diabetes mellitus with multiple 
complications 
C10F311 
Type II diabetes mellitus with multiple 
complications 
C109311 
Type II diabetes mellitus with nephropathy C109C11 
Type II diabetes mellitus with nephropathy C10FC11 
Type II diabetes mellitus with neurological 
complications 
C109211 
Type II diabetes mellitus with neurological 
complications 
C10F211 
Type II diabetes mellitus with neuropathic 
arthropathy 
C109H11 
Type II diabetes mellitus with neuropathic 
arthropathy 
C10FH11 
Type II diabetes mellitus with ophthalmic 
complications 
C10F111 
Type II diabetes mellitus with ophthalmic 
complications 
C109111 
Type II diabetes mellitus with peripheral 
angiopathy 
C109F11 
Type II diabetes mellitus with peripheral 
angiopathy 
C10FF11 
Type II diabetes mellitus with persistent 
microalbuminuria 
C10FM11 
Type II diabetes mellitus with persistent 
proteinuria 
C10FL11 
Type II diabetes mellitus with polyneuropathy C10FB11 
Type II diabetes mellitus with polyneuropathy C109B11 
Type II diabetes mellitus with renal 
complications 
C10F011 
Type II diabetes mellitus with renal 
complications 
C109011 
Type II diabetes mellitus with retinopathy C10F611 
Type II diabetes mellitus with retinopathy C109611 
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Type II diabetes mellitus with ulcer C109411 
Type II diabetes mellitus with ulcer C10F411 
Type II diabetes mellitus without complication C10F911 
Type II diabetes mellitus without complication C109911 
Under care of diabetes specialist nurse 9NN9.00 
Under care of diabetic foot screener 9NND.00 
Under care of diabetic liaison nurse ZL22500 
Unspecified diabetes mellitus with multiple 
complications 
C108z00 
Unstable diabetes 66AJ.11 
Unstable insulin dependent diabetes mellitus C108400 
Unstable insulin dependent diabetes mellitus C10E412 
Unstable type 1 diabetes mellitus C10E400 
Unstable type 1 diabetes mellitus C108412 
Unstable type I diabetes mellitus C10E411 
Unstable type I diabetes mellitus C108411 
[V]Dietary counselling in diabetes mellitus ZV65312 
Diabetic diet 13B1.00 
Diabetic diet - poor compliance 66Aa.00 
Diabetic dietary review 66At.00 
Diabetic dietary review declined 8IAs.00 
Diet advice for insulin-dependent diabetes ZC2C911 
Dietary advice for diabetes mellitus ZC2C800 
Dietary advice for type I diabetes ZC2C900 
Dietary advice for type II diabetes ZC2CA00 
Dietary advice non-insulin-dependent diabetes ZC2CA11 
Type 1 diabetic dietary review 66At011 
Type 2 diabetic dietary review 66At111 
Type I diabetic dietary review 66At000 
Type II diabetic dietary review 66At100 
 
Gout Medications Description, Multilex Code, and BNF Code 
Description Multilex Code BNF Code 
Allopurinol 100mg tablets 97039998 10.01.04.00 
ALLOPURINOL 100mg tablets 98945998 10.01.04.00 
ALLOPURINOL 100mg tablets 92928998 10.01.04.00 
Allopurinol 100mg tablets 98597989 10.01.04.00 
Allopurinol 100mg tablets 99896990 10.01.04.00 
ALLOPURINOL 100mg tablets 99852998 10.01.04.00 
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Allopurinol 100mg tablets 99899990 10.01.04.00 
ALLOPURINOL 100mg tablets 97393998 10.01.04.00 
ALLOPURINOL 100mg tablets 97795998 10.01.04.00 
Allopurinol 100mg tablets 97792990 10.01.04.00 
Allopurinol 100mg tablets 99898990 10.01.04.00 
Allopurinol 100mg tablets 96936990 10.01.04.00 
Allopurinol 100mg tablets 98152990 10.01.04.00 
Allopurinol 100mg tablets 99900990 10.01.04.00 
Allopurinol 300mg tablets 97039997 10.01.04.00 
ALLOPURINOL 300mg tablets 98639998 10.01.04.00 
ALLOPURINOL 300mg tablets 92928997 10.01.04.00 
ALLOPURINOL 300mg tablets 99852997 10.01.04.00 
ALLOPURINOL 300mg tablets 97392998 10.01.04.00 
Allopurinol 300mg tablets 99896989 10.01.04.00 
Allopurinol 300mg tablets 99899989 10.01.04.00 
Allopurinol 300mg tablets 99898989 10.01.04.00 
Allopurinol 300mg tablets 98597990 10.01.04.00 
Allopurinol 300mg tablets 97792989 10.01.04.00 
Allopurinol 300mg tablets 96936989 10.01.04.00 
Allopurinol 300mg tablets 99895989 10.01.04.00 
Allopurinol 300mg tablets 99894989 10.01.04.00 
Allopurinol 300mg tablets 99900989 10.01.04.00 
Allopurinol 300mg tablets 98152989 10.01.04.00 
Allopurinol 300mg tablets 99897989 10.01.04.00 
ALLOPURINOL sf susp 
100mg/5ml 
86921998 10.01.04.02 
Benzbromarone 100mg tablets 80934998 10.01.00.00 
COLCHICINE .1 MG TAB 94122992 10.01.04.00 
COLCHICINE .5 MG TAB 94856992 10.01.04.00 
COLCHICINE 250 MCG CAP 94855992 10.01.04.00 
COLCHICINE 250 MCG TAB 96069992 10.01.04.00 
Colchicine 500microgram tablets 98000998 10.01.04.00 
Colchicine 500microgram tablets 99650990 10.01.04.00 
Colchicine 500microgram tablets 99637990 10.01.04.00 
Colchicine 500microgram tablets 96906990 10.01.04.00 
COLCHICUM & SODIUM 
SALICYLATE MIX 
93850992 10.01.04.00 
Febuxostat 120mg tablets 82371998 10.01.04.00 
FEBUXOSTAT 120mg tablets 82369998 10.01.04.00 
Febuxostat 80mg tablets 82372998 10.01.04.00 
FEBUXOSTAT 80mg tablets 82370998 10.01.04.00 
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Probenecid 500mg tablets 95402998 10.01.04.00 
PROBENECID 500mg tablets 99907998 10.01.04.00 
Probenecid 500mg tablets 86944998 10.01.04.00 
Sulfinpyrazone 100mg tablets 95232998 10.01.04.00 
SULFINPYRAZONE 100mg tablets 87546998 10.01.04.00 
SULFINPYRAZONE 100mg tablets 99949998 10.01.04.00 
Sulfinpyrazone 200mg tablets 95232997 10.01.04.00 
SULFINPYRAZONE 200mg tablets 99949997 10.01.04.00 
SULFINPYRAZONE 200mg tablets 87545998 10.01.04.00 
 
ACEI Description, Multilex Code, and BNF Code 
Description Multilex Code BNF Code 
Ramipril 10mg capsules 94139998 02.05.05.01 
Ramipril 5mg capsules 93567996 02.05.05.01 
Lisinopril 20mg tablets 94748998 02.05.05.01 
Lisinopril 10mg tablets 94749996 02.05.05.01 
Ramipril 2.5mg capsules 93567997 02.05.05.01 
Lisinopril 5mg tablets 94749997 02.05.05.01 
Perindopril erbumine 4mg 
tablets 
93597997 02.05.05.01 
Enalapril 20mg tablets 96795998 02.05.05.01 
Perindopril erbumine 2mg 
tablets 
93597998 02.05.05.01 
Enalapril 10mg tablets 96796996 02.05.05.01 
Lisinopril 2.5mg tablets 94749998 02.05.05.01 
Ramipril 1.25mg capsules 93567998 02.05.05.01 
Enalapril 5mg tablets 96796997 02.05.05.01 
Perindopril erbumine 8mg 
tablets 
91444998 02.05.05.01 
Captopril 25mg tablets 96888997 02.05.05.01 
Captopril 12.5mg tablets 96888998 02.05.05.01 
Enalapril 2.5mg tablets 96796998 02.05.05.01 
Captopril 50mg tablets 96888996 02.05.05.01 
Ramipril 10mg tablets 87903998 02.05.05.01 




Trandolapril 2mg capsules 94603996 02.05.05.01 
Ramipril 5mg tablets 87904998 02.05.05.01 
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Fosinopril 20mg tablets 93136997 02.05.05.01 
Fosinopril 10mg tablets 93136998 02.05.05.01 
Ramipril 2.5mg tablets 87905998 02.05.05.01 
LISINOPRIL 10mg tablets 94751996 02.05.05.01 
LISINOPRIL 5mg tablets 94751997 02.05.05.01 
Quinapril 20mg tablets 94395996 02.05.05.01 
ENALAPRIL MAL 10mg tabs 
x28 
98216996 02.05.05.01 
CAPTOPRIL 25mg tablets 99851997 02.05.05.01 
Perindopril erbumine 4mg / 
Indapamide 1.25mg tablets 
89305998 02.05.05.01 




Quinapril 10mg tablets 94395997 02.05.05.01 
LISINOPRIL 20mg tablets 94750998 02.05.05.01 
ENALAPRIL MAL 20mg tabs 
x28 
97359998 02.05.05.01 






Quinapril 40mg tablets 92731998 02.05.05.01 








LISINOPRIL 2.5mg tablets 94751998 02.05.05.01 
Ramipril 1.25mg tablets 87906998 02.05.05.01 
PERINDOPRIL/TERT-
BUTYLAMINE 2 MG TAB 
96796992 02.05.05.01 
Quinapril 5mg tablets 94395998 02.05.05.01 
Trandolapril 4mg capsules 87622998 02.05.05.01 
CAPTOPRIL 50mg tablets x56 99851996 02.05.05.01 
FOSINOPRIL 10mg tablets 93137998 02.05.05.01 




Perindopril arginine 5mg / 
Indapamide 1.25mg tablets 
84253998 02.05.05.01 
RAMIPRIL 5mg capsules 93568996 02.05.05.01 
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FOSINOPRIL 20mg tablets 93137997 02.05.05.01 










LISINOPRIL 10mg tablets 94753996 02.05.05.01 
RAMIPRIL 2.5mg capsules 93568997 02.05.05.01 
LISINOPRIL 5mg tablets 94753997 02.05.05.01 
LISINOPRIL 20mg tablets 94752998 02.05.05.01 




RAMIPRIL 5mg capsules 87371998 02.05.05.01 
CAPTOPRIL 25mg tablets x56 98877997 02.05.05.01 




QUINAPRIL 10mg tablets 94396997 02.05.05.01 
Cilazapril 5mg tablets 98471997 02.05.05.01 
Co-zidocapt 25mg/50mg tablets 89061998 02.05.05.01 
RAMIPRIL 10mg tablets 87899998 02.05.05.01 
QUINAPRIL 5mg tablets 94396998 02.05.05.01 
RAMIPRIL 1.25mg capsules 93568998 02.05.05.01 
RAMIPRIL 2.5mg capsules 87372998 02.05.05.01 
CAPTOPRIL 12.5mg tablets 98877998 02.05.05.01 
QUINAPRIL 20mg tablets 94396996 02.05.05.01 














Cilazapril 2.5mg tablets 98471998 02.05.05.01 
ENALAPRIL MALEATE 40 
MG TAB 
97347992 02.05.05.01 
LISINOPRIL 2.5mg tablets 94753998 02.05.05.01 
RAMIPRIL 5mg tablets 87900998 02.05.05.01 
Cilazapril 1mg tablets 99660996 02.05.05.01 
CAPTOPRIL + 
HYDROCHLOROTHIAZIDE 





CILAZAPRIL 2.5mg tablets 98169998 02.05.05.01 
RAMIPRIL 2.5mg tablets 87901998 02.05.05.01 
Perindopril arginine 5mg tablets 84040998 02.05.05.01 
CAPTOPRIL 50mg tablets x56 98877996 02.05.05.01 
Verapamil 180mg modified-
release / Trandolapril 2mg 
capsules 
88441998 02.05.05.01 















CILAZAPRIL 1mg tablets 99384996 02.05.05.01 






Ramipril 10mg tablets 94713990 02.05.05.01 
RAMIPRIL 10mg capsules 98153998 02.05.05.01 


















Captopril 5mg/5ml oral 
suspension 
87064998 02.05.05.01 
Lisinopril 5mg/5ml oral solution 87261998 02.05.05.01 
RAMIPRIL 1.25mg tablets 87902998 02.05.05.01 








Enalapril 10mg tablets 96679988 02.05.05.01 
Cilazapril 500microgram tablets 99660997 02.05.05.01 
HYDROCHLOROTHIAZIDE + 
CAPTOPRIL tabs 25mg + 50mg 
94553998 02.05.05.01 
CILAZAPRIL 500mcg tablets 99384997 02.05.05.01 
Perindopril 4mg/5ml oral 
suspension 
86129998 02.05.05.01 




Ramipril 5mg capsules 95146990 02.05.05.01 
Lisinopril 20mg tablets 95688990 02.05.05.01 





tabs 25mg + 12.5mg 
94869997 02.05.05.01 
Ramipril 2.5mg tablets 94719990 02.05.05.01 
CAPTOPRIL 4 MG/ML LIQ 96099992 02.05.05.01 
CAPTOPRIL tabs 2mg 90049998 02.05.05.01 
Ramipril 10mg/5ml oral 
suspension 
85496998 02.05.05.01 
Lisinopril 10mg tablets 95689990 02.05.05.01 
TRANDOLAPRIL + 







Lisinopril 5mg tablets 95789990 02.05.05.01 
CAPTOPRIL oral liq 3mg/5ml 87812998 02.05.05.01 
Moexipril 15mg tablets 90816997 02.05.05.01 




Lisinopril 20mg tablets 95787990 02.05.05.01 
Ramipril 10mg capsules 95145990 02.05.05.01 




Ramipril 2.5mg capsules 95149990 02.05.05.01 
Enalapril 5mg/5ml oral solution 84315998 02.05.05.01 
Lisinopril 5mg/5ml oral 
suspension 
84061998 02.05.05.01 
Enalapril 5mg/5ml oral 
suspension 
84314998 02.05.05.01 
Lisinopril 5mg tablets 95690990 02.05.05.01 
IMIDAPRIL HCL 20mg tablets 90533996 02.05.05.01 
IMIDAPRIL HCL 5mg tablets 90533998 02.05.05.01 
Ramipril 1.25mg capsules 95150990 02.05.05.01 
Enalapril 20mg tablets 96900990 02.05.05.01 
CAPTOPRIL 25mg tablets 89058997 02.05.05.01 
Enalapril 10mg tablets 96902988 02.05.05.01 






Perindopril erbumine 8mg 
tablets 
93329990 02.05.05.01 




CAPTOPRIL 100 MG TAB 97086992 02.05.05.01 
ENALAPRIL MAL tabs titre 
pack 
97359997 02.05.05.01 
Perindopril erbumine 2mg 
tablets 
93331990 02.05.05.01 
Lisinopril 7.5mg/5ml oral 
suspension 
86350998 02.05.05.01 
Enalapril 2.5mg tablets 96902990 02.05.05.01 
CAPTOPRIL 12.5mg tablets 89058998 02.05.05.01 
Ramipril 5mg capsules 95137990 02.05.05.01 
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RAMIPRIL 10mg tablets 87699998 02.05.05.01 
Captopril 50mg tablets 97833988 02.05.05.01 
Ramipril 2.5mg capsules 95129990 02.05.05.01 
Lisinopril 2.5mg tablets 95691990 02.05.05.01 
ENALAPRIL titration pack 96795997 02.05.05.01 
Enalapril 20mg tablets 96689990 02.05.05.01 
Ramipril 5mg/5ml oral solution 81693998 02.05.05.01 
Ramipril 2.5mg capsules 95135990 02.05.05.01 
HYDROCHLOROTHIAZIDE + 
CAPTOPRIL tabs 12.5mg + 
25mg 
94553997 02.05.05.01 
Perindopril erbumine 4mg 
tablets 
92439990 02.05.05.01 
Enalapril 5mg tablets 96679989 02.05.05.01 
Captopril 6.25mg/5ml oral 
suspension 
86454998 02.05.05.01 
Enalapril 5mg tablets 98058990 02.05.05.01 
Lisinopril 2.5mg tablets 95790990 02.05.05.01 
MOEXIPRIL HCL 7.5mg 
tablets 
90817998 02.05.05.01 
ENALAPRIL MAL 10mg tabs 
x28 
93459996 02.05.05.01 
ENALAPRIL wafer 5mg 91958998 02.05.05.01 




Captopril 12.5mg/5ml oral 
suspension 
85460998 02.05.05.01 
Enalapril 2.5mg tablets 96690990 02.05.05.01 
Enalapril 20mg tablets 96678990 02.05.05.01 
ENALAPRIL MALEATE 20mg 
tablets 
97491998 02.05.05.01 
ENALAPRIL MALEATE 10mg 
wafer 
88349996 02.05.05.01 
Enalapril 20mg tablets 96667990 02.05.05.01 
Ramipril 5mg capsules 95101990 02.05.05.01 
Perindopril erbumine 4mg 
tablets 
93330990 02.05.05.01 
Ramipril 10mg capsules 95136990 02.05.05.01 
Captopril 25mg tablets 97833989 02.05.05.01 
MOEXIPRIL HCL 15mg tablets 90817997 02.05.05.01 
Enalapril 20mg tablets 96664990 02.05.05.01 
Ramipril 2.5mg capsules 95138990 02.05.05.01 
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Enalapril 5mg tablets 96180990 02.05.05.01 
Enalapril 5mg tablets 96668989 02.05.05.01 
Ramipril 10mg capsules 94633990 02.05.05.01 
Captopril 50mg tablets 97793988 02.05.05.01 
RAMIPRIL 1.25mg tablets 93727992 02.05.05.01 
Lisinopril 20mg tablets 95678990 02.05.05.01 
Lisinopril 10mg tablets 95674990 02.05.05.01 
Lisinopril 20mg tablets 95712990 02.05.05.01 




Captopril 25mg tablets 97831989 02.05.05.01 
Captopril 25mg tablets 97139989 02.05.05.01 
Captopril 25mg tablets 97821989 02.05.05.01 
Ramipril 2.5mg capsules 95102990 02.05.05.01 
Captopril 25mg tablets 97832989 02.05.05.01 
Captopril 12.5mg tablets 97139990 02.05.05.01 
Ramipril 2.5mg/5ml oral 
solution sugar free 
81099998 02.05.05.01 
Lisinopril 5mg tablets 95675990 02.05.05.01 
Lisinopril 5mg tablets 95680990 02.05.05.01 
Perindopril erbumine 2mg 
tablets 
92887990 02.05.05.01 
Lisinopril 20mg tablets 95673990 02.05.05.01 
ENALAPRIL MALEATE 5mg 
wafer 
88349997 02.05.05.01 
Perindopril erbumine 4mg 
tablets 
92960990 02.05.05.01 
Ramipril 10mg capsules 95127990 02.05.05.01 
Captopril 5mg/5ml oral solution 81128998 02.05.05.01 
ENALAPRIL wafer 2.5mg 96795996 02.05.05.01 
Enalapril 10mg tablets 96661988 02.05.05.01 
Enalapril 10mg tablets 96668988 02.05.05.01 
Captopril 12.5mg tablets 97833990 02.05.05.01 




Captopril 25mg tablets 97040990 02.05.05.01 
Lisinopril 5mg tablets 95684990 02.05.05.01 
CAPTOPRIL 50mg tablets x56 89058996 02.05.05.01 
CAPTOPRIL 50mg tablets 89069996 02.05.05.01 
Ramipril 10mg capsules 95100990 02.05.05.01 
Ramipril 5mg capsules 95128990 02.05.05.01 
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ENALAPRIL MALEATE 5mg 
tabs x2 
93459997 02.05.05.01 




Ramipril 10mg capsules 95058990 02.05.05.01 
Lisinopril 5mg tablets 95717990 02.05.05.01 




ENALAPRIL wafer 20mg 91958996 02.05.05.01 
Captopril 50mg tablets 97039990 02.05.05.01 
Ramipril 5mg capsules 95043990 02.05.05.01 
Enalapril 10mg tablets 96690988 02.05.05.01 
Ramipril 5mg capsules 94510990 02.05.05.01 
Captopril 12.5mg tablets 97793990 02.05.05.01 
RAMIPRIL 1.25mg tablets 87702998 02.05.05.01 
Enalapril 10mg tablets 96687988 02.05.05.01 
Enalapril 5mg tablets 96690989 02.05.05.01 
Captopril 25mg tablets 97793989 02.05.05.01 
Ramipril 10mg capsules 95042990 02.05.05.01 
Ramipril 5mg capsules 95059990 02.05.05.01 
Captopril 50mg tablets 88508996 02.05.05.01 
Enalapril 20mg tablets 96178990 02.05.05.01 
Ramipril 1.25mg capsules 95061990 02.05.05.01 
Captopril 50mg tablets 97832988 02.05.05.01 
Ramipril 5mg capsules 95134990 02.05.05.01 
Perindopril erbumine 4mg 
tablets 
92886990 02.05.05.01 
Perindopril erbumine 8mg 
tablets 
92885990 02.05.05.01 
Co-zidocapt 25mg/50mg tablets 95635990 02.05.05.01 
ENALAPRIL MALEATE 20mg 
wafer 
88350998 02.05.05.01 
Enalapril 10mg tablets 96665988 02.05.05.01 
Ramipril 5mg/5ml oral 
suspension 
81098998 02.05.05.01 
Enalapril 5mg tablets 96687989 02.05.05.01 
Enalapril 5mg tablets 96902989 02.05.05.01 
CAPTOPRIL 25mg tablets 89069997 02.05.05.01 
Lisinopril 20mg tablets 95699990 02.05.05.01 
CAPTOPRIL oral susp 2mg/5ml 84572998 02.05.05.01 
Captopril 12.5mg tablets 88508998 02.05.05.01 
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Ramipril 10mg capsules 94833990 02.05.05.01 
Lisinopril 2.5mg tablets 95702990 02.05.05.01 
Enalapril 2.5mg tablets 92887998 02.05.05.01 
Captopril 12.5mg tablets 97831990 02.05.05.01 
Ramipril 1.25mg capsules 95103990 02.05.05.01 
Ramipril 5mg tablets 95147990 02.05.05.01 
Enalapril 20mg tablets 96686990 02.05.05.01 
Captopril 12.5mg tablets 97832990 02.05.05.01 
Lisinopril 10mg tablets 95700990 02.05.05.01 
Enalapril 5mg tablets 96665989 02.05.05.01 
Lisinopril 10mg tablets 94561990 02.05.05.01 
Lisinopril 10mg tablets 93896990 02.05.05.01 
Captopril 12.5mg tablets 97820990 02.05.05.01 
Ramipril 2.5mg capsules 94511990 02.05.05.01 
Ramipril 2.5mg tablets 95148990 02.05.05.01 
Lisinopril 5mg tablets 95723990 02.05.05.01 








Enalapril 20mg tablets 89543998 02.05.05.01 
Ramipril 5mg capsules 94834990 02.05.05.01 
Captopril 5mg tablets 84568998 02.05.05.01 
Lisinopril 20mg tablets 95682990 02.05.05.01 







Ramipril 2.5mg capsules 95044990 02.05.05.01 
RAMIPRIL 2.5mg tablets 94040992 02.05.05.01 




CAPTOPRIL 25mg tablets x56 89102997 02.05.05.01 
RAMIPRIL 1.25mg capsules 87226998 02.05.05.01 
QUINAPRIL 5mg tablets 86898998 02.05.05.01 
Enalapril 2.5mg tablets 96687990 02.05.05.01 
Enalapril 5mg tablets 92887997 02.05.05.01 
Enalapril 10mg tablets 92887996 02.05.05.01 
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Lisinopril 5mg tablets 95701990 02.05.05.01 
Lisinopril 2.5mg tablets 95724990 02.05.05.01 
Enalapril 2.5mg tablets 96658990 02.05.05.01 
Ramipril 10mg/5ml oral solution 79276979 02.05.05.01 






Felodipine 5mg modified-release 
/ Ramipril 5mg tablets 
91780997 02.00.00.00 
RAMIPRIL + FELODIPINE mr 
tab 5mg + 5mg 
90445997 02.00.00.00 
Felodipine 2.5mg modified-
release / Ramipril 2.5mg tablets 
91780998 02.00.00.00 
RAMIPRIL + FELODIPINE mr 









Lipid Lowering Agent Description, Multilex Code, and BNF Code 
Description Multilex Code BNF Code 
Simvastatin 40mg tablets 93619996 02.12.00.00 
Simvastatin 20mg tablets 93619997 02.12.00.00 
Atorvastatin 10mg tablets 89311998 02.12.00.00 
Simvastatin 10mg tablets 93619998 02.12.00.00 
Atorvastatin 20mg tablets 89311997 02.12.00.00 
Atorvastatin 40mg tablets 89311996 02.12.00.00 
Ezetimibe 10mg tablets 92292998 02.12.00.00 
Pravastatin 40mg tablets 93244996 02.12.00.00 
Rosuvastatin 10mg tablets 88534998 02.12.00.00 
Atorvastatin 80mg tablets 90310998 02.12.00.00 
Pravastatin 20mg tablets 93244997 02.12.00.00 




Simvastatin 80mg tablets 92220998 02.12.00.00 
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Rosuvastatin 20mg tablets 90973998 02.12.00.00 
SIMVASTATIN 40mg tablets 87916998 02.12.00.00 
Fluvastatin 40mg capsules 92804997 02.12.00.00 
Eicosapentaenoic acid 460mg / 
Docosahexaenoic acid 380mg 
capsules 
89800998 02.12.00.00 
Fluvastatin 20mg capsules 92804998 02.12.00.00 
Rosuvastatin 5mg tablets 86468998 02.12.00.00 
BEZAFIBRATE 400mg m/r 
tablets 
97895997 02.12.00.00 
Ciprofibrate 100mg tablets 97723998 02.12.00.00 
SIMVASTATIN 10mg tablets 93620998 02.12.00.00 
Bezafibrate 200mg tablets 95952998 02.12.00.00 
SIMVASTATIN 20mg tablets 87917998 02.12.00.00 






ATORVASTATIN 10mg tablets 89306998 02.12.00.00 
Fenofibrate micronised 267mg 
capsules 
88298997 02.12.00.00 
BEZAFIBRATE 400mg m/r 
tablets 
99014998 02.12.00.00 




Rosuvastatin 40mg tablets 92410998 02.12.00.00 
Colestyramine 4g oral powder 
sachets 
96678998 02.12.00.00 








ATORVASTATIN 20mg tablets 89306997 02.12.00.00 
Colestyramine sugar free pdr 99197998 02.12.00.00 




ROSUVASTATIN 10mg tablets 92409998 02.12.00.00 












FENOFIBRATE 160mg m/r 
tablets 
94799998 02.12.00.00 
Fenofibrate 200mg capsules 94188997 02.12.00.00 
ATORVASTATIN 40mg tablets 89306996 02.12.00.00 
BEZAFIBRATE 400mg m/r 
tablets 
83187998 02.12.00.00 




Simvastatin 40mg / Ezetimibe 
10mg tablets 
86796998 02.12.00.00 
Gemfibrozil 300mg capsules 96295998 02.12.00.00 
Fenofibrate micronised 67mg 
capsules 
88298998 02.12.00.00 
SIMVASTATIN + EZETIMIBE 


















Simvastatin 20mg / Ezetimibe 
10mg tablets 
86798998 02.12.00.00 
FLUVASTATIN 40mg capsules 92805997 02.12.00.00 
SIMVASTATIN 40mg tablets 93620996 02.12.00.00 
Simvastatin 40mg tablets 95549990 02.12.00.00 
Colestipol 5g granules sachets 
sugar free 
94662998 02.12.00.00 
Colestyramine 4g oral powder 
sachets sugar free 
93541998 02.12.00.00 
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ROSUVASTATIN 20mg tablets 92408998 02.12.00.00 
CLOFIBRATE 500mg capsules 98455998 02.12.00.00 






SIMVASTATIN sf oral susp 
20mg/5ml 
86020998 02.12.04.00 




SIMVASTATIN + EZETIMIBE 
tabs 20mg + 10mg 
86789998 02.12.00.00 




Nicotinic acid 50mg tablets 98066997 02.12.00.00 
Simvastatin 80mg / Ezetimibe 
10mg tablets 
86794998 02.12.00.00 
CERIVASTATIN Na 200mcg 
tabs 
89153997 02.12.00.00 
NICOTINIC ACID 1000mg m/r 
tab 
87850998 02.12.00.00 
FENOFIBRATE caps 100mg 94188998 02.12.00.00 
COLESTIPOL orang 5g/sach 
grans 
94661997 02.12.00.00 
FENOFIBRATE 67mg capsules 88297998 02.12.00.00 
ATORVASTATIN 80mg tablets 90309998 02.12.00.00 
NICOTINIC ACID 500mg m/r 
tabs 
87852998 02.12.00.00 
Eicosapentaenoic acid 170mg / 
Docosahexaenoic acid 115mg 
capsules 
94925998 02.12.00.00 
ROSUVASTATIN 5mg tablets 86467998 02.12.00.00 
SIMVASTATIN sf oral susp 
40mg/5ml 
83099998 02.12.00.00 
SIMVASTATIN + EZETIMIBE 
tabs 80mg + 10mg 
86787998 02.12.00.00 




ISPAG HSK 3.5g ornge s/f gran 89617998 02.12.00.00 
PROBUCOL tabs 250mg 95401998 02.12.00.00 
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Nicotinic acid 1g modified-
release tablets 
87853998 02.12.00.00 
FLUVASTATIN 80mg m/r 
tablets 
91194998 02.12.00.00 




NICOTINIC ACID 750mg m/r 
tabs 
87851998 02.12.00.00 
Simvastatin 80mg tablets 95448990 02.12.00.00 
Simvastatin 40mg tablets 95501990 02.12.00.00 
Nicotinic acid 500mg modified-
release tablets 
87855998 02.12.00.00 




CERIVASTATIN Na 300mcg 
tabs 
89153996 02.12.00.00 
COLESTIPOL orang 5g/sach 
grans 
87760998 02.12.00.00 
CERIVASTATIN Na 400mcg 
tabs 
92447998 02.12.00.00 
Nicotinic acid 1g / Laropiprant 
20mg modified-release tablets 
83594998 02.12.00.00 
NICOFURANOSE tabs 250mg 95728998 02.12.00.00 
Nicotinic acid 750mg modified-
release tablets 
87854998 02.12.00.00 
SIMVASTATIN 80mg tablets 92471998 02.12.00.00 
NICOTINIC ACID starter pack 87848998 02.12.00.00 
COLESEVELAM 625mg tablets 84267998 02.12.00.00 
PROBUCOL 250mg tablets 99456998 02.12.00.00 
Simvastatin 20mg tablets 95550990 02.12.00.00 
Simvastatin 20mg tablets 95494990 02.12.00.00 
Simvastatin 20mg tablets 95502990 02.12.00.00 
CHOLESTYRAMINE POW 94827992 02.12.00.00 
Simvastatin 40mg tablets 95493990 02.12.00.00 
Simvastatin 20mg tablets 95450990 02.12.00.00 
Simvastatin 10mg tablets 95551990 02.12.00.00 












BEZAFIBRATE 400mg m/r 
tablets 
89089998 02.12.00.00 
NICOTINIC ACID mr tab 
375mg + 500mg + 750mg 
87849998 02.12.00.00 
Simvastatin 80mg tablets 95500990 02.12.00.00 
NICOTINIC ACID tabs 25mg 98066998 02.12.00.00 
Simvastatin 80mg tablets 95185990 02.12.00.00 
Simvastatin 20mg tablets 95482990 02.12.00.00 
Eicosapentaenoic acid 170mg/g / 
Docosahexaenoic acid 115mg/g 
oral liquid 
94925997 02.12.00.00 
Simvastatin 40mg tablets 95449990 02.12.00.00 
COLESTIPOL + ASPARTAME 
grans 
94605998 02.12.00.00 
BEZAFIBRATE 400mg m/r 
tablets 
95805998 02.12.00.00 
Simvastatin 40mg tablets 95481990 02.12.00.00 
Simvastatin 10mg tablets 95495990 02.12.00.00 
Atorvastatin 10mg chewable 
tablets sugar free 
81051998 02.12.00.00 
Pravastatin 40mg tablets 94849990 02.12.00.00 
HEXOPAL 200 MG TAB 95098992 02.12.00.00 
Bezafibrate 200mg tablets 96656990 02.12.00.00 
Simvastatin 10mg tablets 95508990 02.12.00.00 
Simvastatin 10mg tablets 95451990 02.12.00.00 
Simvastatin 20mg tablets 95475990 02.12.00.00 
Simvastatin 40mg tablets 95471990 02.12.00.00 
Simvastatin 40mg/5ml oral 
suspension sugar free 
62570979 02.12.00.00 
NICOTINIC ACID 500 MG 
TAB 
97800992 02.12.00.00 
Simvastatin 40mg tablets 95478990 02.12.00.00 
Pravastatin 10mg tablets 94789990 02.12.00.00 
Colestyramine 4g oral powder 
sachets sugar free 
96134990 02.12.00.00 
Atorvastatin 20mg chewable 
tablets sugar free 
81049998 02.12.00.00 
COLESTYRAMINE + 
ASPARTAME sf pwdr 4g 
90653998 02.12.00.00 
Simvastatin 80mg tablets 95442990 02.12.00.00 
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Simvastatin 40mg tablets 95486990 02.12.00.00 
Simvastatin 40mg tablets 95443990 02.12.00.00 
Simvastatin 20mg/5ml oral 
suspension sugar free 
62597979 02.12.00.00 
Simvastatin 20mg tablets 95479990 02.12.00.00 
Pravastatin 20mg tablets 94782990 02.12.00.00 
Pravastatin 20mg tablets 94850990 02.12.00.00 
Simvastatin 20mg tablets 95472990 02.12.00.00 
Colestyramine 4g oral powder 
sachets sugar free 
95847990 02.12.00.00 
Simvastatin 10mg tablets 95483990 02.12.00.00 
COLESTIPOL HCl GRA 93851992 02.12.00.00 
Gemfibrozil 600mg tablets 97808989 02.12.00.00 
Colestyramine 4g oral powder 
sachets sugar free 
97655990 02.12.00.00 
Simvastatin 40mg tablets 95474990 02.12.00.00 
ATORVASTATIN 10mg chew 
tabs 
81050998 02.12.00.00 
Simvastatin 20mg tablets 95487990 02.12.00.00 
Pravastatin 10mg tablets 94851990 02.12.00.00 
Simvastatin 40mg tablets 95277990 02.12.00.00 
Atorvastatin 60mg tablets 58151979 02.12.04.00 
Bezafibrate 200mg tablets 96685989 02.12.00.00 
Simvastatin 20mg tablets 95406990 02.12.00.00 
Bezafibrate 200mg tablets 93838990 02.12.00.00 
Fenofibrate micronised 200mg 
capsules 
96021990 02.12.00.00 
FISH OIL(CONC) oral emulsion 97078996 02.12.00.00 
Atorvastatin 30mg tablets 58153979 02.12.04.00 
Simvastatin 20mg/5ml oral 
suspension sugar free 
92154990 02.12.00.00 
SIMVASTATIN 10mg tablets 87373998 02.12.00.00 
Simvastatin 80mg tablets 94927990 02.12.00.00 
ATORVASTATIN 20mg chew 
tabs 
81048998 02.12.00.00 
Fenofibrate micronised 200mg 
capsules 
92549990 02.12.00.00 
COLESTYRAM SUG FREE pdr 
4g 
91316998 02.12.00.00 
BEZAFIBRATE 400mg m/r 
tablets 
89401998 02.12.00.00 




Simvastatin 40mg tablets 93871990 02.12.00.00 
Simvastatin 20mg tablets 94407990 02.12.00.00 
Pravastatin 20mg tablets 94830990 02.12.00.00 
Simvastatin 20mg tablets 95278990 02.12.00.00 
Nicotinic acid 50mg tablets 99725990 02.12.00.00 




Simvastatin 20mg tablets 97494979 02.12.00.00 
Simvastatin 10mg tablets 95480990 02.12.00.00 




Simvastatin 10mg tablets 95445990 02.12.00.00 
Simvastatin 40mg tablets 95405990 02.12.00.00 
Eicosapentaenoic acid 460mg / 
Docosahexaenoic acid 380mg 
capsules 
92329998 02.12.06.00 
Acipimox 250mg capsules 94883998 02.12.00.00 
ACIPIMOX 250mg capsules 94882998 02.12.00.00 
 
Diuretics Description, Multilex Code, and BNF Code  
Description Multilex Code BNF Code 
Bendroflumethiazide 2.5mg tablets 97217998 02.02.01.00 
Furosemide 40mg tablets 97114997 02.02.02.00 
Furosemide 20mg tablets 97114998 02.02.02.00 
Co-amilofruse 5mg/40mg tablets 93212998 02.02.04.00 
Bendroflumethiazide 5mg tablets 97217997 02.02.01.00 
Bumetanide 1mg tablets 95936998 02.02.02.00 
Spironolactone 25mg tablets 97201998 02.02.03.00 
CO-AMILOFRUSE tablets 98742998 02.02.04.00 
Indapamide 1.5mg modified-release 
tablets 
96129997 02.02.01.00 
Indapamide 2.5mg tablets 96129998 02.02.01.00 
CO-AMILOZIDE 5/50mg tablets 99405998 02.02.04.00 
Amiloride 5mg tablets 97224998 02.02.03.00 
CO-TRIAMTERZIDE 50/25mg tabs 99709998 02.02.04.00 
Co-amilozide 5mg/50mg tablets 94146997 02.02.04.00 
Co-amilofruse 2.5mg/20mg tablets 93212997 02.02.04.00 
CO-TENIDONE 100/25mg tablets 98301998 02.04.00.00 
Co-tenidone 50mg/12.5mg tablets 93219998 02.04.00.00 
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Co-tenidone 100mg/25mg tablets 93219997 02.04.00.00 
BUMETAN+K 500mcg/7.7mmol tabs 98941998 02.02.08.00 
Spironolactone 50mg tablets 97201997 02.02.03.00 
AMILORIDE+CYCLOPEN 2.5/0.25mg 93401998 02.02.04.00 
Spironolactone 100mg tablets 97201996 02.02.03.00 
CO-TENIDONE 50/12.5mg tablets 99068998 02.04.00.00 
INDAPAMIDE 2.5mg tablets 97295998 02.02.01.00 
Lisinopril 20mg / Hydrochlorothiazide 
12.5mg tablets 
99328998 02.05.05.01 
FUROSEMIDE + AMILORIDE tabs 
40mg + 5mg 
96475998 02.02.04.00 
CYCLOPENTHIAZIDE -K tabs 99372998 02.02.08.00 
TRIAMT+FUROSEMIDE 50/40mg tabs 99620998 02.02.04.00 
ATENOLOL + CHLORTALIDONE tabs 
100mg+25mg 
95021997 02.04.00.00 
Co-amilozide 2.5mg/25mg tablets 94146998 02.02.04.00 






CO-AMILOZIDE 2.5/25mg tablets 97486998 02.02.04.00 
Co-triamterzide 50mg/25mg tablets 97731998 02.02.04.00 
CO-AMILOFRUSE 2.5/20mg tablets 98742997 02.02.04.00 
CO-AMILOFRUSE tablets 94917998 02.02.04.00 
Losartan 50mg / Hydrochlorothiazide 
12.5mg tablets 
91240998 02.05.05.02 
BUMETANIDE 1mg tablets 99867998 02.02.02.00 
CAPTOP+HYDROCHL 50/25mg tabs 94868998 02.05.05.00 
Bumetanide 500microgram / Potassium 
chloride 573mg (potassium 7.7mmol) 
modified-release tablets 
95934998 02.02.08.00 
Metolazone 5mg tablets 95827998 02.02.01.00 
Perindopril erbumine 4mg / Indapamide 
1.25mg tablets 
89305998 02.05.05.01 
Lisinopril 10mg / Hydrochlorothiazide 
12.5mg tablets 
99328997 02.05.05.01 
Irbesartan 300mg / Hydrochlorothiazide 
12.5mg tablets 
91089997 02.05.05.02 
INDAPAMIDE 1.5mg m/r tablets 89237998 02.02.01.00 
AMILORIDE HCl + 
HYDROCHLOROTHIAZIDE tabs 5mg 
+ 50mg 
94546998 02.02.04.00 
LISINO+HYDROCHL 20/12.5mg tabs 99162998 02.05.05.01 
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FUROSEMIDE+K 40mg/8mmol tabs 99735998 02.02.08.00 
FUROSEMIDE 40mg tablets 99491997 02.02.02.00 
CO-PRENOZIDE 160/0.25mg tabs 99031998 02.04.00.00 
CO-FLUMACTONE-50 tablets 97636997 02.02.04.00 
Amiloride 2.5mg / Cyclopenthiazide 
250microgram tablets 
93399998 02.02.04.00 
Bumetanide 5mg tablets 95936997 02.02.02.00 
Chlortalidone 50mg tablets 96685998 02.02.01.00 
BENDROFLU+K 2.5mg/8.4mmol tabs 99367998 02.02.08.00 
Irbesartan 150mg / Hydrochlorothiazide 
12.5mg tablets 
91089998 02.05.05.02 





BUMETANIDE + AMILORIDE tabs 93194998 02.02.04.00 
Furosemide 500mg tablets 97113998 02.02.02.00 
BENDROFLUMETHIAZIDE 5mg tablet 99943997 02.02.01.00 
Furosemide 40mg/5ml oral solution 
sugar free 
92829998 02.02.02.00 
SPIRONOL+FUROSMID 50/20mg caps 99493998 02.02.04.00 
Cyclopenthiazide 500microgram tablets 96587998 02.02.01.00 
CYCLOPENTHIAZIDE 500mcg tabs 99373998 02.02.01.00 
CO-FLUMACTONE-25 tablets 97636998 02.02.04.00 
Hydrochlorothiazide 25mg tablets 96212998 02.02.01.00 
FUROSEMIDE+K 20mg/10mmol tabs 99494998 02.02.08.00 
IRBES+HYDROCHL 300/12.5mg tabs 89292997 02.05.05.02 
LOSART+HYDROCHLTHZ 50/12.5 tab 90077998 02.05.05.02 
ENALAP+HYDROCHL 20/12.5mg tabs 99272998 02.05.05.01 
Telmisartan 80mg / Hydrochlorothiazide 
12.5mg tablets 
97251998 02.05.05.02 
Perindopril arginine 5mg / Indapamide 
1.25mg tablets 
84253998 02.05.05.01 
FUROSEMIDE + TRIAMTERENE tabs 
40mg + 50mg 
96474998 02.02.04.00 
Losartan 100mg / Hydrochlorothiazide 
25mg tablets 
86522998 02.05.05.02 
TIMOLOL+BENDROFL 10/2.5mg tabs 98816998 02.04.00.00 
FUROSEMIDE 40mg tablets 93078998 02.02.02.00 
Xipamide 20mg tablets 95616998 02.02.01.00 
Amiloride 5mg / Bumetanide 1mg tablets 93192998 02.02.04.00 




XIPAMIDE 20mg tablets 99734998 02.02.01.00 
IRBES+HYDROCHL 150/12.5mg tabs 89292998 02.05.05.02 




CHLORTALIDONE 50mg tablets 99548998 02.02.01.00 
PINDOLOL+CLOPAMIDE 10/5mg tabs 98963998 02.04.00.00 
FUROSEMIDE + AMILORIDE tabs 
20mg + 2.5mg 
96475997 02.02.04.00 
Furosemide 20mg/5ml oral solution 
sugar free 
97114996 02.02.02.00 
Bendroflumethiazide 2.5mg tablets 99792990 02.02.01.00 
Co-amilofruse 10mg/80mg tablets 93212996 02.02.04.00 
Valsartan 160mg / Hydrochlorothiazide 
12.5mg tablets 
87428998 02.05.05.02 
Torasemide 5mg tablets 92742997 02.02.02.00 








CO-AMILOZIDE 5/50mg tablets 93633998 02.02.04.00 
Telmisartan 40mg / Hydrochlorothiazide 
12.5mg tablets 
90547998 02.05.05.02 
CO-TRIAMTERZIDE 50/25mg tabs 96069998 02.02.04.00 




CO-AMILOFRUSE tablets 97721998 02.02.04.00 
FUROSEMIDE 40mg tablets 99723998 02.02.02.00 
SOTALOL + 
HYDROCHLOROTHIAZIDE tabs 
160mg + 25mg 
95267997 02.04.00.00 
Valsartan 80mg / Hydrochlorothiazide 
12.5mg tablets 
87214998 02.05.05.02 
SPIRONOLACTONE 25mg tablets 97637998 02.02.03.00 
BENDROFLUMETHIAZIDE 5mg tablet 99368998 02.02.01.00 
PROPRANOL+BENDR 80/2.5mg caps 98447998 02.04.00.00 
Torasemide 10mg tablets 92742996 02.02.02.00 
FUROSEMIDE 20mg tablets 99491998 02.02.02.00 
CHLORTHAL tab+K m/r tab pack 99547998 02.02.08.00 
PERIND ERB+INDAP 4/1.25mg tabs 88955998 02.05.05.01 
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ACEBU+HYDROCH 200/12.5mg tabs 99151998 02.04.00.00 
Triamterene 50mg / Furosemide 40mg 
tablets 
95125998 02.02.04.00 
SPIRONOLACTONE 100mg tablets 97637996 02.02.03.00 
Co-zidocapt 25mg/50mg tablets 89061998 02.05.05.01 
Bendroflumethiazide 2.5mg / Potassium 
chloride 630mg (potassium 8.4mmol) 
modified-release tablets 
95094998 02.02.08.00 
Bumetanide 1mg/5ml oral solution sugar 
free 
95936996 02.02.02.00 
SPIRONOLACTONE 50mg tablets 97637997 02.02.03.00 
CO-TRIAMTERZIDE 50/25mg tabs 96205998 02.02.04.00 
SPIRONOLACTONE caps 100mg 95261998 02.02.03.00 
CYCLOPENTHIAZIDE -K tabs 96586998 02.02.08.00 
SOTAL+HYDROCHLOR 160/25mg tab 99118998 02.04.00.00 
Valsartan 160mg / Hydrochlorothiazide 
25mg tablets 
87424998 02.05.05.02 
Triamterene 50mg capsules 95129998 02.02.03.00 




Quinapril 10mg / Hydrochlorothiazide 
12.5mg tablets 
93101998 02.05.05.01 
Furosemide 40mg tablets 99586989 02.02.02.00 
CAPTOP+HYDROCHL 50/25mg tabs 97060998 02.05.05.01 




POLYTHIAZIDE 1mg tablets 99366998 02.02.01.00 
CO-TENIDONE 100/25mg tablets 96070997 02.04.00.00 
OXPRENOLOL + 
CYCLOPENTHIAZIDE mr tab 
160mg+0.25mg 
93210998 02.04.00.00 
Hydrochlorothiazide 50mg tablets 96212997 02.02.01.00 
Olmesartan medoxomil 20mg / 
Hydrochlorothiazide 12.5mg tablets 
86093998 02.05.05.02 
Furosemide 50mg/5ml oral solution 
sugar free 
92829997 02.02.02.00 
SPIRONOLACTONE sf susp 50mg/5ml 92820998 02.02.03.00 
Spironolactone 50mg / Furosemide 20mg 
capsules 
95257998 02.02.04.00 
Co-flumactone 50mg/50mg tablets 93211997 02.02.04.00 
Eplerenone 50mg tablets 87218998 02.02.03.00 
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METOLAZONE 5mg tablets 99429998 02.02.01.00 
CO-AMILOZIDE 5/50mg tablets 99849992 02.02.04.00 
Co-flumactone 25mg/25mg tablets 93211998 02.02.04.00 
Torasemide 2.5mg tablets 92742998 02.02.02.00 






Losartan 100mg / Hydrochlorothiazide 
12.5mg tablets 
84178998 02.05.05.02 
CO-AMILOFRUSE tablets 83025998 02.02.04.00 
CAPTOPRIL + 
HYDROCHLOROTHIAZIDE tabs 
50mg + 25mg 
94869998 02.05.05.01 
LISINO+HYDROCHL 20/12.5mg tabs 83448998 02.05.05.01 
BUMETANIDE 1mg/5mL liquid 98833998 02.02.02.00 
Furosemide 40mg tablets 98679990 02.02.02.00 
Amiloride 5mg/5ml oral solution sugar 
free 
97224997 02.02.03.00 
Polythiazide 1mg tablets 95469998 02.02.01.00 
CO-AMILOFRUSE 10/80mg tablets 98742996 02.02.04.00 
CO-AMILOZIDE 5/50mg tablets 82385998 02.02.04.00 
CHLOROTHIAZIDE tabs 500mg 96696998 02.02.01.00 
Irbesartan 300mg / Hydrochlorothiazide 
25mg tablets 
85219998 02.05.05.02 
FRUSEM tab+POTASS m/r tab pck 98868998 02.02.08.00 
ATENOLOL + AMILORIDE & 
HYDROCHLOROTHIAZIDE caps 
94670998 02.04.00.00 
BENDROFLUMETHIAZIDE 5mg tablet 99894997 02.02.01.00 
TRIAMT+BENZTHIAZ 50/25mg caps 99707998 02.02.04.00 
Pindolol 10mg / Clopamide 5mg tablets 95514998 02.04.00.00 
VALSRT+HYDROCHL 160/12.5mg tab 87426998 02.05.05.02 
LISINO+HYDROCHL 20/12.5mg tabs 93748998 02.05.05.01 
SPIRONOLACTONE sf susp 25mg/5ml 92828996 02.02.03.00 






CAPTOP+HYDROCHL 25/12.5mg tabs 94868997 02.05.05.01 
QUINAPRIL+HYDROCHLOROTHIAZ 93102998 02.05.05.01 
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IDE 
CO-TENIDONE 50/12.5mg tablets 96070998 02.04.00.00 






TELMIS+HYDROCHL 80/12.5mg tabs 99686998 02.05.05.02 
Bendroflumethiazide 2.5mg tablets 99790990 02.02.01.00 
Bendroflumethiazide 2.5mg tablets 98336989 02.02.01.00 
HYDROCHLOROTHIAZIDE + 
TIMOLOL & AMILORIDE tabs 25mg + 
10mg + 2.5mg 
94549998 02.04.00.00 
Furosemide 20mg tablets 99586990 02.02.02.00 
CO-AMILOZIDE 5/50mg/5mL mixt 99405997 02.02.04.00 
FUROSEMIDE 40mg tablets 99939998 02.02.02.00 




FUROSEMIDE 40mg tablets 97092998 02.02.02.00 
TRIAMT+CHLORTAL 50mg/50mg tabs 98731998 02.02.04.00 
PIRETANIDE caps 6mg 98773998 02.02.02.00 
AMILORIDE HCL 5mg tablets 99424998 02.02.03.00 
AMILORIDE HCl + FUROSEMIDE 
tabs 5mg + 40mg 
94547997 02.02.04.00 
Metoprolol 100mg / Hydrochlorothiazide 
12.5mg tablets 
94634997 02.04.00.00 
BUMETANIDE 5mg tablets 98834998 02.02.02.00 
CO-AMILOZIDE 5/50mg tablets 96208998 02.02.04.00 
MEFRUSIDE 25mg tablets 99916998 02.02.01.00 
MEFRUSIDE tabs 25mg 95908998 02.02.01.00 
CHLOROTHIAZIDE 500mg tablets 99161998 02.02.01.00 
SPIRONOLACTONE sf susp 5mg/5ml 92828998 02.02.03.00 
CO-AMILOFRUSE 2.5/20mg tablets 83621998 02.02.04.00 
FRUSEMIDE 40MG/8MMOL 
POTASSIUM S/R MG TAB 
93327992 02.02.08.00 
Olmesartan medoxomil 20mg / 
Hydrochlorothiazide 25mg tablets 
86092998 02.05.05.02 
ATENOLOL+BENDRO 25/1.25mg cap 89288998 02.04.00.00 
NADOLOL+BENDROFLU 40/5mg tabs 99808998 02.04.00.00 




AMILORIDE HCl + 94546996 02.02.04.00 
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HYDROCHLOROTHIAZIDE soln 5mg 
+ 50mg/5ml 
TELMIS+HYDROCHL 40/12.5mg tabs 90549998 02.05.05.02 
Co-amilofruse 5mg/40mg tablets 98516990 02.02.04.00 
TRIAMTERENE 50mg capsules 99708998 02.02.03.00 
LISINO+HYDROCHL 10/12.5mg tabs 83449998 02.05.05.01 
NADOLOL+BENDROFLU 80/5mg tabs 98367998 02.04.00.00 
Bendroflumethiazide 2.5mg/5ml oral 
suspension 
86128998 02.02.01.00 







Furosemide 40mg / Potassium chloride 
600mg (potassium 8mmol) modified-
release tablets 
96476998 02.02.08.00 
Indapamide 2.5mg tablets 97804990 02.02.01.00 
SPIRONOLACTONE 100mg tablets 98736996 02.02.03.00 
BENDROFLUMETHIAZIDE 5mg tablet 92736997 02.02.01.00 
METOLAZONE 500mcg tablets 93846998 02.02.01.00 
Bendroflumethiazide 5mg tablets 99792989 02.02.01.00 
FRUSEMIDE 
20MG/SPIRONOLACTONE 50MG MG 
CAP 
97492992 02.02.04.00 
Chlorothiazide 250mg/5ml oral 
suspension 
87956998 02.02.01.00 
Propranolol 160mg modified-release / 
Bendroflumethiazide 5mg capsules 
94422997 02.04.00.00 
CO-AMILOZIDE 5/50mg tablets 94903998 02.02.04.00 
CHLORTHALIDONE 100mg tablets 99548997 02.02.01.00 
AMILORIDE HCl + FUROSEMIDE 
tabs 2.5mg + 20mg 
94547998 02.02.04.00 
CHLORTALIDONE tabs 100mg 96685997 02.02.01.00 
HYDROCHLOROTHIAZIDE + 
CAPTOPRIL tabs 25mg + 50mg 
94553998 02.05.05.01 
Furosemide 20mg / Potassium chloride 
750mg (potassium 10mmol) modified-
release tablets 
96476997 02.02.08.00 
Furosemide 40mg tablets 99584990 02.02.02.00 





Co-amilofruse 2.5mg/20mg tablets 98009990 02.02.04.00 
HYDROCHLOROTHIAZIDE + 
AMILORIDE tabs 25mg+2.5mg 
96211998 02.02.04.00 
FUROSEMIDE + AMILORIDE tabs 
80mg + 10mg 
96475996 02.02.04.00 
Co-amilozide 5mg/50mg tablets 98641989 02.02.04.00 
Bendroflumethiazide 2.5mg tablets 97557990 02.02.01.00 
TIMOLOL+BENDROFL 10/2.5mg tabs 87288998 02.04.00.00 
SPIRONOLACTONE 100mg tablets 94765997 02.02.03.00 
FRUSEMIDE 20MG/POTASSIUM 
10MMOL S/R MG TAB 
93323992 02.02.08.00 
LISINO+HYDROCHL 10/12.5mg tabs 93748997 02.05.05.01 
Co-amilofruse 2.5mg/20mg tablets 97877989 02.02.04.00 
OLMESAR+HYDROCH 20/12.5mg tabs 86090998 02.05.05.02 
CAPTOPRIL + 
HYDROCHLOROTHIAZIDE tabs 
25mg + 12.5mg 
94869997 02.05.05.01 
IRBES+HYDROCHL 300mg/25mg tabs 85218998 02.05.05.02 
Co-amilofruse 5mg/40mg tablets 98009989 02.02.04.00 
Bendroflumethiazide 2.5mg tablets 98144989 02.02.01.00 
TORASEMIDE 10mg tablets 92743996 02.02.02.00 
INDAPAMIDE 2.5mg tablets 92670998 02.02.01.00 
FUROSEMIDE 40mg/5mL s/f soln 89394997 02.02.02.00 
Furosemide 20mg tablets 98679988 02.02.02.00 
HYDROCHLOROTHIAZIDE + 
AMILORIDE tabs 50mg + 5mg 
96211996 02.02.04.00 
Bumetanide 1mg tablets 97830990 02.02.02.00 
Furosemide 40mg tablets 98550989 02.02.02.00 
SPIRONOLACTONE 100mg capsules 97279996 02.02.03.00 
Bendroflumethiazide 5mg tablets 98336990 02.02.01.00 
CHLORTALIDONE + ATENOLOL tabs 
12.5mg+50mg 
96683998 02.04.00.00 
BENDRO+K 2.5mg/7.7mmol mr tab 91812998 02.02.08.00 
TORASEMIDE 2.5mg tablets 92743998 02.02.02.00 
SOTAL+HYDROCHLO 80/12.5mg tab 95264998 02.04.00.00 
Triamterene 50mg / Chlortalidone 50mg 
tablets 
95123998 02.02.04.00 
Co-zidocapt 12.5mg/25mg tablets 89061997 02.05.05.01 
Bendroflumethiazide 2.5mg tablets 94889990 02.02.01.00 




TRIAMTERENE tabs 25mg+50mg 
96210998 02.02.04.00 
 89 
AMILORIDE S/F 5 MG/5ML SOL 96883992 02.02.03.00 









LOSARTAN tabs 12.5mg + 50mg 
91577998 02.05.05.02 
PIRETANIDE caps 6mg 95499998 02.02.02.00 
Spironolactone 25mg tablets 99378990 02.02.03.00 
METOPROLOL TARTRATE + 
CHLORTALIDONE tabs 
94635998 02.04.00.00 
Bumetanide 1mg tablets 97828990 02.02.02.00 
Telmisartan 80mg / Hydrochlorothiazide 
25mg tablets 
83721998 02.05.05.02 
SPIRONOLACTONE 10 MG/5ML LIQ 96862992 02.02.03.00 




LISINO+HYDROCHL 20/12.5mg tabs 83436998 02.05.05.01 
SPIRONOLACTONE sf susp 
100mg/5ml 
92820997 02.02.03.00 
TIMOLOL+BENDROFL 20/5mg tabs 95159998 02.04.00.00 
Co-tenidone 50mg/12.5mg tablets 98344990 02.04.00.00 
Co-tenidone 100mg/25mg tablets 98636989 02.04.00.00 
CHLORTALIDONE + ATENOLOL tabs 
25mg+100mg 
96683997 02.04.00.00 
Furosemide 20mg tablets 98550990 02.02.02.00 
SPIRONOLACTONE 25mg tablets 94765998 02.02.03.00 
BENDROFLUMETHIAZIDE + 
TIMOLOL MALEATE tabs 2.5mg + 
10mg 
95011998 02.04.00.00 
Triamterene 50mg / Benzthiazide 25mg 
capsules 
95126998 02.02.04.00 
Co-amilofruse 5mg/40mg tablets 96439990 02.02.04.00 
Amiloride 5mg tablets 99878990 02.02.03.00 







Bendroflumethiazide 5mg tablets 99790989 02.02.01.00 
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FUROSEMIDE 20mg/5mL s/f soln 89394998 02.02.02.00 
CO-AMILOZIDE (amiloride & 
hydrochlorothiazide) oral soln 5mg + 
50mg/5ml 
94146996 02.02.04.00 
Spironolactone 25mg tablets 98083990 02.02.03.00 
SPIRONOLACTONE 50mg tablets 97279997 02.02.03.00 
Furosemide 40mg tablets 98549990 02.02.02.00 
AMILORIDE HCL 5mg tablets 94675998 02.02.03.00 
Acebutolol 200mg / Hydrochlorothiazide 
12.5mg tablets 
96990998 02.04.00.00 
Co-amilofruse 5mg/40mg tablets 97872990 02.02.04.00 
Bumetanide 1mg tablets 97172990 02.02.02.00 






Nadolol 40mg / Bendroflumethiazide 
5mg tablets 
95765998 02.04.00.00 
Bendroflumethiazide 2.5mg / Potassium 
chloride 573mg (potassium 7.7mmol) 
modified-release tablets 
95094997 02.02.08.00 
Furosemide 20mg tablets 99584988 02.02.02.00 
Bendroflumethiazide 5mg tablets 97556990 02.02.01.00 
Bendroflumethiazide 5mg tablets 98144990 02.02.01.00 
EPLERENONE 25mg tablets 87217998 02.02.03.00 
Olmesartan medoxomil 40mg / 
Hydrochlorothiazide 12.5mg tablets 
82197998 02.05.05.02 
Furosemide 40mg tablets 97021990 02.02.02.00 
Spironolactone 25mg tablets 98616990 02.02.03.00 





FUROSEMIDE 1mg/1mL liquid 99492998 02.02.02.00 
Bendroflumethiazide 2.5mg tablets 96219990 02.02.01.00 




Metoprolol 200mg modified-release / 
Hydrochlorothiazide 25mg tablets 
94634998 02.04.00.00 
ETHACRYNIC ACID 50mg tablets 99702998 02.02.02.00 
Spironolactone 25mg tablets 98180989 02.02.03.00 
ETACRYNIC ACID tabs 50mg 96774998 02.02.02.00 
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Furosemide 40mg tablets 98626990 02.02.02.00 




Bumetanide 1mg tablets 97066990 02.02.02.00 
HYDROFLUMETHIAZIDE tabs 50mg 96203998 02.02.01.00 
SPIRONOLACTONE 25mg tablets 97279998 02.02.03.00 
HYDROCHLOROTHIAZIDE + 
LOSARTAN tabs 25mg + 100mg 
86521998 02.05.05.02 
FUROSEMIDE 500mg tablets 96472998 02.02.02.00 
AMILORIDE 10 MG TAB 93399992 02.02.03.00 






HYDROFLUMETHIAZIDE 50mg tabs 97425998 02.02.01.00 
Spironolactone 100mg tablets 98616988 02.02.03.00 
Amiloride 5mg tablets 97892990 02.02.03.00 
Furosemide 50mg/5ml solution for 
injection ampoules 
95120997 02.02.02.00 
Spironolactone 50mg tablets 99378989 02.02.03.00 
HYDROCHLOROTHIAZIDE + 




80mg + 12.5mg 
95267998 02.04.00.00 
BENDROFLUAZIDE K 2.5 MG TAB 94699992 02.02.08.00 
Co-amilofruse 5mg/40mg tablets 97877990 02.02.04.00 
HYDROCHLOROTHIAZIDE + 
LOSARTAN tabs 12.5mg + 100mg 
84177998 02.05.05.02 
Co-tenidone 100mg/25mg tablets 98344989 02.04.00.00 
Co-amilozide 5mg/50mg tablets 99679990 02.02.04.00 




Co-amilozide 5mg/50mg tablets 99680990 02.02.04.00 
PENBUTOL+FRUSEM 40/20mg tabs 98775998 02.04.00.00 
HYDROCHLOROTHIAZIDE + 
VALSARTAN tabs 12.5mg + 80mg 
87213998 02.05.05.02 
TIMOLOL MALEATE + 
BENDROFLUMETHIAZIDE tabs 20mg 
+ 5mg 
95161997 02.04.00.00 
Indapamide 2.5mg tablets 97747990 02.02.01.00 
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AMILORIDE HCl + FUROSEMIDE 
tabs 10mg + 80mg 
94547996 02.02.04.00 
BENDROFLUAZIDE K TAB 94700992 02.02.08.00 
Spironolactone 50mg tablets 98616989 02.02.03.00 
Co-amilofruse 2.5mg/20mg tablets 96062990 02.02.04.00 
BENDROFLUAZIDE 10 MG TAB 94702992 02.02.01.00 
HYDROCHLOROTHIAZIDE + 
VALSARTAN tabs 25mg + 160mg 
87422998 02.05.05.02 
Furosemide 20mg tablets 95301990 02.02.02.00 
FUROSEMIDE 50mg/5mL s/f soln 89394996 02.02.02.00 
CO-AMILOZIDE 5/50mg tablets 93605998 02.02.04.00 
CHLORTHALIDONE 
25MG/POTASSIUM6.7MMOL S/R MG 
TAB 
93250992 02.02.08.00 





CAPTOPRIL tabs 12.5mg + 25mg 
94553997 02.05.05.01 
Chlorothiazide 150mg/5ml oral 
suspension 
86041998 02.02.01.00 
CO-TENIDONE 100/25mg tablets 97710997 02.04.00.00 
Co-tenidone 50mg/12.5mg tablets 98181989 02.04.00.00 
Furosemide 40mg tablets 96116990 02.02.02.00 
Co-amilozide 2.5mg/25mg tablets 98247989 02.02.04.00 
Furosemide 20mg tablets 97021989 02.02.02.00 
Indapamide 2.5mg tablets 96862990 02.02.01.00 




LISINO+HYDROCHL 10/12.5mg tabs 83435998 02.05.05.01 
TIMOLOL MALEATE + AMILORIDE 
& HYDROCHLOROTHIAZIDE tabs 
94551998 02.04.00.00 
Co-amilofruse 5mg/40mg tablets 96899990 02.02.04.00 
Spironolactone 100mg tablets 99378988 02.02.03.00 
Nadolol 80mg / Bendroflumethiazide 
5mg tablets 
95765997 02.04.00.00 
Furosemide 40mg/5ml oral solution 
sugar free 
93517990 02.02.02.00 
NATRILIX 5 MG TAB 94243992 02.02.01.00 
BENDROFLUMETHIAZIDE + 
PROPRANOLOL caps 2.5mg + 80mg 
95014998 02.04.00.00 
HYDROCHLOROTHIAZIDE 50mg 99677997 02.02.01.00 
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tabs 
INDAPAMIDE 2.5mg tablets 91607998 02.02.01.00 
Spironolactone 25mg tablets 94593990 02.02.03.00 
BENDROFLUMETHIAZIDE + 
NADOLOL tabs 5mg + 40mg 
95012998 02.04.00.00 
BENDRO+K 2.5mg/7.7mmol mr tab 99841997 02.02.08.00 
BENDROFLUMETHIAZIDE 5mg tablet 98943997 02.02.01.00 
SPIRONOLACTONE 50mg tablets 97600998 02.02.03.00 
Co-tenidone 50mg/12.5mg tablets 97769990 02.04.00.00 
Co-amilofruse 5mg/40mg tablets 96913990 02.02.04.00 
Bumetanide 1mg tablets 97077990 02.02.02.00 
CAPTOP+HYDROCHL 25/12.5mg tabs 83623998 02.05.05.01 
Furosemide 500mg tablets 99584989 02.02.02.00 
Bendroflumethiazide 2.5mg tablets 99791990 02.02.01.00 
TELMIS+HYDROCHL 80mg/25mg tabs 83720998 02.05.05.02 
CO-AMILOFRUSE tablets 89622998 02.02.04.00 
ESIDREX-K TAB 94982992 02.02.08.00 
CHLOROTHIAZIDE/SPIRONOLACTO
NE/LACTOSE MG POW 
94817992 02.02.04.00 
Spironolactone 25mg tablets 99379990 02.02.03.00 
Bumetanide 1mg tablets 96724990 02.02.02.00 
Bendroflumethiazide 2.5mg tablets 98797990 02.02.01.00 
Spironolactone 50mg/5ml oral 
suspension 
81077998 02.02.03.00 
CLOPAMIDE + POTASSIUM eff tab 99875998 02.02.08.00 
Amiloride 5mg tablets 99874990 02.02.03.00 
METHYCLOTHIAZIDE 5mg tablets 95861998 02.02.01.00 
HYDROCHLOROTHIAZIDE + 
ATENOLOL & AMILORIDE caps 
94671998 02.04.00.00 
FUROSEMIDE + PENBUTOLOL tabs 96473998 02.04.00.00 
CO-TENIDONE 50/12.5mg tablets 91079998 02.04.00.00 
Amiloride 5mg tablets 99877990 02.02.03.00 
OLMESARTAN MEDOXOMIL + 
AMLODIPINE & 
HYDROCHLOROTHIAZIDE tabs 
20mg + 5mg + 12.5mg 
81461998 02.02.01.00 
Bumetanide 5mg tablets 97830989 02.02.02.00 
BENDROFLUMETHIAZIDE + 
PROPRANOLOL mr cap 5mg + 160mg 
95014997 02.04.00.00 
FUROSEMIDE oral liq 85004998 23.00.00.00 
Bendroflumethiazide 2.5mg tablets 96313990 02.02.01.00 




INDAPAMIDE 1.5mg m/r tablets 82870998 02.02.01.00 




OLMESARTAN MEDOXOMIL tabs 
12.5mg + 20mg 
86039998 02.05.05.02 
Amiloride 5mg tablets 99875990 02.02.03.00 












AMILORIDE HCL 5mg tablets 93612998 02.02.03.00 
ALDACTIDE 100 MG TAB 94605992 02.02.04.00 
CO-AMILOFRUSE 2.5/20mg tablets 92797998 02.02.04.00 
Spironolactone 25mg/5ml oral 
suspension 
81078998 02.02.03.00 
FUROSEMIDE 20mg/2mL injection 94213992 02.02.02.00 
EPLERENONE 50mg tablets 87216998 02.02.03.00 
Lisinopril 20mg / Hydrochlorothiazide 
12.5mg tablets 
94992990 02.05.05.01 
BENDROFLUAZIDE 1 MG TAB 94419992 02.02.01.00 
Co-tenidone 100mg/25mg tablets 98181990 02.04.00.00 
Co-amilofruse 10mg/80mg tablets 98009988 02.02.04.00 
INDAPAMIDE 1.5mg m/r tablets 83713998 02.02.01.00 
DIL+HYDROCHLOR 150/12.5mg cap 90434998 02.06.02.00 
Spironolactone 100mg tablets 98083988 02.02.03.00 
Spironolactone 50mg tablets 98082990 02.02.03.00 
HYDROCHLOROTHIAZIDE + 
METOPROLOL TARTRATE tabs 
12.5mg + 100mg 
94633997 02.04.00.00 
OLMESAR+HYDROCH 40/12.5mg tabs 82196998 02.05.05.02 
SPIRONOLACTONE sf susp 50mg/5ml 98095990 02.02.03.00 
Amiloride 5mg tablets 96934990 02.02.03.00 
CO-TENIDONE 100/25mg tablets 91079997 02.04.00.00 
Co-tenidone 100mg/25mg tablets 97769989 02.04.00.00 
CO-TENIDONE 50/12.5mg tablets 97710998 02.04.00.00 
Bumetanide 1mg tablets 96317990 02.02.02.00 
Co-amilozide 5mg/50mg tablets 97771990 02.02.04.00 
CO-FLUMACTONE-25 tablets 92803998 02.02.04.00 
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CO-AMILOZIDE 5/50mg tablets 94865998 02.02.04.00 
CHLOROTHIAZIDE 250 MG SYR 94811992 02.02.01.00 
Co-zidocapt 25mg/50mg tablets 95635990 02.05.05.01 
METHYCLOTHIAZIDE tabs 5mg 95862998 02.02.01.00 
TRIAMT+CHLORTHAL 50/25mg tabs 98731997 02.02.04.00 




Bendroflumethiazide 2.5mg tablets 96380990 02.02.01.00 
CO-AMILOZIDE 5/50mg tablets 91211998 02.02.04.00 
FUROSEMIDE 50mg/5mL injection 98744998 02.02.02.00 
CO-TENIDONE 50/12.5mg tablets 93345992 02.04.00.00 
HYDROCHLOROTHIAZIDE + 
OLMESARTAN MEDOXOMIL tabs 
25mg + 20mg 
86040998 02.05.05.02 
SPIRONOLACTONE sf susp 25mg/5ml 98096988 02.02.03.00 




HYDROCHLOROTHIAZIDE mr cap 
150mg + 12.5mg 
90433998 02.06.02.00 
CHLOROTHIAZIDE 60MG / 
SPIRONOLACTONE 6MG POW 
94818992 02.02.04.00 
CHLOROTHIAZIDE SACHETS 60 MG 94804992 02.02.01.00 
Bumetanide 1mg tablets 96321990 02.02.02.00 
OLMESARTAN MEDOXOMIL + 
AMLODIPINE & 
HYDROCHLOROTHIAZIDE tabs 
40mg + 5mg + 12.5mg 
81460998 02.02.01.00 
OLMESARTAN MEDOXOMIL + 
AMLODIPINE & 
HYDROCHLOROTHIAZIDE tabs 
40mg + 10mg + 12.5mg 
81459998 02.02.01.00 
CHLOROTHIAZIDE 25 MG LIQ 94101992 02.02.01.00 
Furosemide 40mg tablets 95002990 02.02.02.00 
CHLOROTHIAZIDE 250mg/5mL susp 87955998 02.02.01.00 
CHLOROTHIAZIDE 50 MG SUS 94803992 02.02.01.00 
Furosemide 20mg tablets 92302990 02.02.02.00 
Co-tenidone 100mg/25mg tablets 96895989 02.04.00.00 
Co-amilofruse 2.5mg/20mg tablets 96912990 02.02.04.00 
SPIRONOLACTONE oral liq 85517998 02.02.03.00 
Furosemide 20mg tablets 96342990 02.02.02.00 
Bendroflumethiazide 2.5mg tablets 95453990 02.02.01.00 
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SPIRONOLACTONE 100mg tablets 97188997 02.02.03.00 
ABBOLACTONE 25 MG TAB 93662992 02.02.03.00 
CO-TENIDONE 100/25mg tablets 93344992 02.04.00.00 
LISINO+HYDROCHL 20/12.5mg tabs 87515998 02.05.05.01 
FRUSEMIDE 250mg/25mL syringe 99300998 02.02.02.00 
CHLOROTHIAZIDE / 





Spironolactone 25mg/5ml oral solution 64745979 02.02.03.00 
HYDROFLUMETHIAZIDE + 
SPIRONOLACTONE tabs 50mg+50mg 
96202997 02.02.04.00 
Spironolactone 50mg tablets 98083989 02.02.03.00 
Bendroflumethiazide 2.5mg tablets 95321990 02.02.01.00 
Spironolactone 100mg/5ml oral 
suspension 
79158979 02.02.03.00 









/SPIRONOLACTONE 4MG POW 
94819992 02.02.04.00 
Bumetanide 5mg tablets 97066989 02.02.02.00 
Spironolactone 10mg/5ml oral 
suspension 
79164979 02.02.03.00 
Furosemide 20mg tablets 93903990 02.02.02.00 
INDAPAMIDE 1.5mg m/r tablets 82818998 02.02.01.00 
CAPTOP+HYDROCHL 25/12.5mg tabs 90740998 02.05.05.01 
CLOPAMIDE + POTASSIUM eff tab 91551998 02.02.08.00 
Indapamide 1.5mg modified-release 
tablets 
92687990 02.02.01.00 
Spironolactone 50mg tablets 98180990 02.02.03.00 
Furosemide 40mg tablets 95602990 02.02.02.00 
Furosemide 40mg/5ml oral solution 
sugar free 
99286979 02.02.02.00 
Spironolactone 5mg/5ml oral suspension 79180979 02.02.03.00 
OLMESARTAN MEDOXOMIL + 
AMLODIPINE & 
HYDROCHLOROTHIAZIDE tabs 
40mg + 5mg + 25mg 
81458998 02.02.01.00 
Chlorothiazide 250mg tablets 82102998 02.02.01.00 
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Acetazolamide 250mg/5ml oral solution 81134979 02.02.07.00 
Co-tenidone 50mg/12.5mg tablets 96895990 02.04.00.00 
Furosemide 40mg/5ml oral solution 
sugar free 
93468990 02.02.02.00 
Torasemide 5mg tablets 95143990 02.02.02.00 
CLOREXOLONE 10 MG TAB 93690992 02.02.01.00 
CHLOROTHIAZIDE/SPIRONOLACTO
NE SACHETS 100 MG 
94003992 02.02.04.00 
BENDROFLUMETHIAZIDE + 
NADOLOL tabs 5mg + 80mg 
95012997 02.04.00.00 
HYDROCHLOROTHIAZIDE 
/METOPROLOL TARTRATE 25 MG 
TAB 
95120992 02.04.00.00 
TRIAMTERENE + CHLORTALIDONE 
tabs 50mg + 25mg 
95123997 02.02.04.00 
CHLOROTHIAZIDE / 









Spironolactone 10mg/5ml oral solution 64747979 02.02.03.00 
Spironolactone 5mg/5ml oral solution 64741979 02.02.03.00 
Furosemide 50mg/5ml oral suspension 69171979 02.02.02.00 
Spironolactone 5mg/5ml / Chlorothiazide 
50mg/5ml oral suspension 
68037979 02.02.04.00 
Furosemide 500mg tablets 98679989 02.02.02.00 
HYDROCHLOROTHIAZIDE + 
METOPROLOL TARTRATE mr tab 









B-Blockers Description, Multilex Code, and BNF Code 
Description Multilex Code BNF Code 
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Atenolol 50mg tablets 96940997 02.04.00.00 
Atenolol 25mg tablets 94929997 02.04.00.00 
Atenolol 100mg tablets 96940998 02.04.00.00 
Bisoprolol 5mg tablets 94783998 02.04.00.00 
Bisoprolol 2.5mg tablets 89659998 02.04.00.00 
Propranolol 40mg tablets 97123997 02.04.00.00 
Bisoprolol 10mg tablets 94783997 02.04.00.00 
Propranolol 10mg tablets 97123998 02.04.00.00 
Propranolol 80mg modified-release 
capsules 
95378998 02.04.00.00 
Metoprolol 50mg tablets 95826998 02.04.00.00 
Bisoprolol 1.25mg tablets 94783996 02.04.00.00 
PROPRANOLOL 80mg m/r capsules 98702998 02.04.00.00 
Sotalol 40mg tablets 95270998 02.04.00.00 
CO-TENIDONE 100/25mg tablets 98301998 02.04.00.00 
Sotalol 80mg tablets 95270997 02.04.00.00 
Co-tenidone 50mg/12.5mg tablets 93219998 02.04.00.00 
Nebivolol 5mg tablets 90919998 02.04.00.00 
Propranolol 160mg modified-release 
capsules 
95378997 02.04.00.00 
Co-tenidone 100mg/25mg tablets 93219997 02.04.00.00 
ATENOLOL 50mg tablets 98300998 02.04.00.00 
ATENOLOL 100mg tablets 99067998 02.04.00.00 
CO-TENIDONE 50/12.5mg tablets 99068998 02.04.00.00 
PROPRANOLOL 160mg m/r capsules 99536998 02.04.00.00 
Metoprolol 100mg tablets 95826997 02.04.00.00 
Propranolol 80mg tablets 97123996 02.04.00.00 
ATENOLOL + CHLORTALIDONE tabs 
100mg+25mg 
95021997 02.04.00.00 
Bisoprolol 7.5mg tablets 89659996 02.04.00.00 
ATENOLOL + CHLORTALIDONE tabs 
50mg+12.5mg 
95021998 02.04.00.00 
Celiprolol 200mg tablets 94672998 02.04.00.00 
Bisoprolol 3.75mg tablets 89659997 02.04.00.00 
Carvedilol 3.125mg tablets 93692996 02.04.00.00 
Carvedilol 12.5mg tablets 93692998 02.04.00.00 
Carvedilol 6.25mg tablets 89397998 02.04.00.00 
Carvedilol 25mg tablets 93692997 02.04.00.00 
OXPRENOLOL 160mg m/r tablets 99132998 02.04.00.00 
ATENOLOL+NIFEDIP 50/20mg m/r 94726998 02.04.00.00 
Labetalol 100mg tablets 96032998 02.04.00.00 
PROPRANOLOL 40mg tablets 98381997 02.04.00.00 
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Timolol 10mg tablets 94573998 02.04.00.00 
Labetalol 200mg tablets 96032997 02.04.00.00 
CO-PRENOZIDE 160/0.25mg tabs 99031998 02.04.00.00 
CELIPROLOL 200mg tablets 94637998 02.04.00.00 
BISOPROLOL FUMARATE 10mg tabs 94808997 02.04.00.00 
PROPRANOLOL 10mg tablets 98381998 02.04.00.00 
ATENOL+CO-AMILOZ 50/2.5/25mg 97949998 02.04.00.00 
ATENOLOL+NIFEDIP 50/20mg m/r 94732998 02.04.00.00 
ATENOLOL 25mg tablets 93608998 02.04.00.00 
BISOPROLOL FUMARATE 5mg tabs 94808998 02.04.00.00 
METOPROLOL 50mg tablets 99892998 02.04.00.00 
Oxprenolol 160mg modified-release 
tablets 
95662998 02.04.00.00 
Oxprenolol 40mg tablets 97125997 02.04.00.00 
ATENOLOL 50mg tablets 93561998 02.04.00.00 
Atenolol 50mg / Nifedipine 20mg 
modified-release capsules 
94669998 02.04.00.00 
Atenolol 25mg/5ml oral solution sugar 
free 
94929998 02.04.00.00 
Celiprolol 400mg tablets 94672997 02.04.00.00 
BISOPROLOL FUMARATE 10mg tabs 94804998 02.04.00.00 
Oxprenolol 80mg tablets 97125996 02.04.00.00 
TIMOLOL+CO-AMILOZ 10/2.5/25mg 98398998 02.04.00.00 
Metoprolol 200mg modified-release 
tablets 
95825998 02.04.00.00 
OXPRENOLOL 40mg tablets 98285997 02.04.00.00 
BISOPROLOL FUMARATE 5mg tabs 94802998 02.04.00.00 
Acebutolol 200mg capsules 96992997 02.04.00.00 
TIMOLOL+BENDROFL 10/2.5mg tabs 98816998 02.04.00.00 
Sotalol 160mg tablets 95270996 02.04.00.00 
Propranolol 160mg tablets 97122998 02.04.00.00 
SOTALOL 80mg tablets 99119998 02.04.00.00 
Labetalol 400mg tablets 94813997 02.04.00.00 
OXPRENOLOL 80mg tablets 98285996 02.04.00.00 
METOPROLOL 100mg tablets 99892997 02.04.00.00 
METOPROLOL 200mg m/r tablets 98603998 02.04.00.00 
Acebutolol 100mg capsules 96992998 02.04.00.00 
PINDOLOL+CLOPAMIDE 10/5mg tabs 98963998 02.04.00.00 
PROPRANOLOL 80mg tablets 98381996 02.04.00.00 
LABETALOL 100mg tablets 98286997 02.04.00.00 
ATENOLOL 25mg tablets 93561996 02.04.00.00 
ATENOLOL 100mg tablets 93561997 02.04.00.00 
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Acebutolol 400mg tablets 96992996 02.04.00.00 
ATENOLOL 50mg tablets 94679998 02.04.00.00 
Pindolol 5mg tablets 95515998 02.04.00.00 
Oxprenolol 20mg tablets 97125998 02.04.00.00 




NEBIVOLOL 5mg tablets 90918998 02.04.00.00 
LABETALOL 200mg tablets 98286996 02.04.00.00 
BISOPROLOL FUMARATE 2.5mg tabs 89658997 02.04.00.00 
ACEBUTOLOL 200mg capsules 98851997 02.04.00.00 
SOTALOL + 
HYDROCHLOROTHIAZIDE tabs 
160mg + 25mg 
95267997 02.04.00.00 
Nebivolol 2.5mg tablets 82687998 02.04.00.00 
METOPROLOL 100mg tablets 99460997 02.04.00.00 
Nadolol 80mg tablets 95766997 02.04.00.00 
PROPRANOL+BENDR 80/2.5mg caps 98447998 02.04.00.00 
ACEBUTOLOL 100mg capsules 98851998 02.04.00.00 
ATENOLOL 100mg tablets 94679997 02.04.00.00 
ACEBU+HYDROCH 200/12.5mg tabs 99151998 02.04.00.00 
Labetalol 50mg tablets 94813998 02.04.00.00 
METOPROLOL 50mg tablets 99460998 02.04.00.00 
SOTALOL 40mg tablets 98297998 02.04.00.00 
ACEBUTOLOL 400mg tablets 98851996 02.04.00.00 
CELIPROLOL 400mg tablets 94637997 02.04.00.00 
SOTALOL 160mg tablets 99119997 02.04.00.00 
SOTAL+HYDROCHLOR 160/25mg tab 99118998 02.04.00.00 
NIFEDIPINE + ATENOLOL caps 20mg 
+ 50mg 
94668998 02.04.00.00 
Atenolol 50mg tablets 98591989 02.04.00.00 
OXPRENOLOL 20mg tablets 98285998 02.04.00.00 
CO-TENIDONE 100/25mg tablets 96070997 02.04.00.00 
OXPRENOLOL + 






NADOLOL 80mg tablets 98368997 02.04.00.00 
SOTALOL 80mg tablets 98297997 02.04.00.00 
Atenolol 25mg / Bendroflumethiazide 
1.25mg capsules 
89290998 02.04.00.00 
OXPRENOLOL tabs 160mg 97124998 02.04.00.00 
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BISOPROLOL FUMARAT 1.25mg tabs 89658998 02.04.00.00 
Nadolol 40mg tablets 95766998 02.04.00.00 
LABETALOL 400mg tablets 98894998 02.04.00.00 
BISOPROLOL FUMARATE 5mg tabs 89656998 02.04.00.00 
TIMOLOL 10mg tablets 98404998 02.04.00.00 
Atenolol 25mg tablets 98798988 02.04.00.00 
ATENOLOL + AMILORIDE & 
HYDROCHLOROTHIAZIDE caps 
94670998 02.04.00.00 
NADOLOL 40mg tablets 98368998 02.04.00.00 
Pindolol 10mg / Clopamide 5mg tablets 95514998 02.04.00.00 
Timolol 10mg / Bendroflumethiazide 
2.5mg tablets 
95161998 02.04.00.00 
OXPRENOLOL 160mg tablets 98284998 02.04.00.00 
TIMOLOL 10mg tablets 99891998 02.04.00.00 
PROPRANOLOL 40mg tablets 98299997 02.04.00.00 
Atenolol 100mg tablets 99169989 02.04.00.00 
CO-TENIDONE 50/12.5mg tablets 96070998 02.04.00.00 
ATENOLOL 50mg tablets 93562998 02.04.00.00 
Propranolol 10mg/5ml oral solution 
sugar free 
97122996 02.04.00.00 






Atenolol 50mg tablets 98799990 02.04.00.00 
PROPRANOLOL 80mg m/r capsules 93746998 02.04.00.00 
HYDROCHLOROTHIAZIDE + 
TIMOLOL & AMILORIDE tabs 25mg + 
10mg + 2.5mg 
94549998 02.04.00.00 




Atenolol 50mg tablets 99278990 02.04.00.00 
ATENOLOL 25mg/5mL syrup 99067997 02.04.00.00 
Metoprolol 100mg / Hydrochlorothiazide 
12.5mg tablets 
94634997 02.04.00.00 
PROPRANOLOL oral soln 50mg/5ml 92827997 02.04.00.00 
PINDOLOL 5mg tablets 98961998 02.04.00.00 
ATENOLOL+BENDRO 25/1.25mg cap 89288998 02.04.00.00 
Atenolol 25mg tablets 97558990 02.04.00.00 
NADOLOL+BENDROFLU 40/5mg tabs 99808998 02.04.00.00 
Atenolol 100mg tablets 98591990 02.04.00.00 
ATENOLOL 25mg tablets 94679996 02.04.00.00 
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PROPRANOLOL 160mg tablets 98380998 02.04.00.00 
Pindolol 15mg tablets 95515997 02.04.00.00 
NADOLOL+BENDROFLU 80/5mg tabs 98367998 02.04.00.00 




PROPRANOLOL 40mg tablets 95995997 02.04.00.00 
Metoprolol 50mg tablets 99501990 02.04.00.00 
LABETALOL 50mg tablets 98286998 02.04.00.00 
CARVEDILOL 25mg tablets 93691997 02.04.00.00 
BISOPROLOL FUMARATE 10mg tabs 89656996 02.04.00.00 
CELIPROLOL 200mg tablets 85789998 02.04.00.00 
Sotalol 200mg tablets 95269998 02.04.00.00 
PROPRANOLOL 10mg tablets 95995998 02.04.00.00 
METOPROLOL 200mg m/r tablets 99461998 02.04.00.00 
Propranolol 160mg modified-release / 
Bendroflumethiazide 5mg capsules 
94422997 02.04.00.00 
CARVEDILOL 12.5mg tablets 93691998 02.04.00.00 
Atenolol 25mg tablets 99278988 02.04.00.00 
Atenolol 100mg tablets 99278989 02.04.00.00 
PROPRANOLOL 80mg m/r capsules 88896998 02.04.00.00 
METOPROLOL 200mg m/r tablets 97680992 02.04.00.00 
ATENOLOL 25mg tablets 93562996 02.04.00.00 
ATENOLOL 100mg tablets 93562997 02.04.00.00 
Propranolol 80mg modified-release 
capsules 
98451989 02.04.00.00 
Propranolol 40mg/5ml oral solution 
sugar free 
92827998 02.04.00.00 
BISOPROLOL FUMARATE 7.5mg tabs 89656997 02.04.00.00 
CARVEDILOL 6.25mg tablets 89396998 02.04.00.00 
Propranolol 10mg tablets 98676990 02.04.00.00 
BISOPROLOL FUMARAT 3.75mg tabs 89658996 02.04.00.00 
SOTALOL 200mg tablets 98297996 02.04.00.00 
TIMOLOL+BENDROFL 10/2.5mg tabs 87288998 02.04.00.00 
Metoprolol 50mg/5ml oral suspension 95140998 02.04.00.00 
PROPRANOLOL 80mg tablets 98299996 02.04.00.00 
Bisoprolol 5mg tablets 96349990 02.04.00.00 
Atenolol 50mg tablets 99169990 02.04.00.00 
OXPRENOLOL 80mg tablets 85959998 02.04.00.00 
CARVEDILOL 3.125mg tablets 93691996 02.04.00.00 
OXPRENOLOL 40mg tablets 85960998 02.04.00.00 
PROPRANOLOL 160mg m/r capsules 96025997 02.04.00.00 
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CHLORTALIDONE + ATENOLOL tabs 
12.5mg+50mg 
96683998 02.04.00.00 
PROPRANOLOL 80mg tablets 95995996 02.04.00.00 
CELIPROLOL 400mg tablets 85788998 02.04.00.00 
Sotalol 40mg tablets 97136990 02.04.00.00 
Metoprolol 50mg tablets 97801990 02.04.00.00 
Atenolol 50mg tablets 88077997 02.04.00.00 
SOTAL+HYDROCHLO 80/12.5mg tab 95264998 02.04.00.00 
Sotalol 80mg tablets 97856990 02.04.00.00 




Atenolol 50mg tablets 96924989 02.04.00.00 
Atenolol 25mg tablets 98591988 02.04.00.00 
METOPROLOL TARTRATE + 
CHLORTALIDONE tabs 
94635998 02.04.00.00 
TIMOLOL+BENDROFL 20/5mg tabs 95159998 02.04.00.00 
PROPRANOLOL 160mg m/r capsules 97861998 02.04.00.00 
Co-tenidone 50mg/12.5mg tablets 98344990 02.04.00.00 
Co-tenidone 100mg/25mg tablets 98636989 02.04.00.00 
TIMOLOL 10mg tablets 87290998 02.04.00.00 
Metoprolol 50mg tablets 98482990 02.04.00.00 




TIMOLOL MALEATE tabs 2.5mg + 
10mg 
95011998 02.04.00.00 
Metoprolol 50mg tablets 97740990 02.04.00.00 
Metoprolol 50mg tablets 96849990 02.04.00.00 
Atenolol 50mg tablets 98143990 02.04.00.00 
PROPRANOLOL 20 MG TAB 93771992 02.04.00.00 
Atenolol 25mg tablets 99169988 02.04.00.00 
Acebutolol 200mg / Hydrochlorothiazide 
12.5mg tablets 
96990998 02.04.00.00 
Propranolol 40mg tablets 99419989 02.04.00.00 
SOTALOL HCl S/R 80 MG TAB 95602992 02.04.00.00 
Bisoprolol 10mg tablets 96348989 02.04.00.00 
Bisoprolol 10mg tablets 96349989 02.04.00.00 
BETAXOLOL HCL 20mg tablets 95956998 02.04.00.00 
Atenolol 25mg tablets 88077998 02.04.00.00 
Bisoprolol 10mg / Hydrochlorothiazide 
6.25mg tablets 
92889998 02.04.00.00 





Nadolol 40mg / Bendroflumethiazide 
5mg tablets 
95765998 02.04.00.00 
Bisoprolol 2.5mg/5ml oral suspension 81997998 02.04.00.00 
Bisoprolol 5mg tablets 96348990 02.04.00.00 
BISOPROLOL FUMARATE 2.5mg tabs 86098998 02.04.00.00 
Propranolol 10mg tablets 99419990 02.04.00.00 
Metoprolol 100mg tablets 99501989 02.04.00.00 
OXPRENOLOL 20mg tablets 85961998 02.04.00.00 
Propranolol 80mg modified-release 
capsules 
95855990 02.04.00.00 
Atenolol 50mg tablets 98798990 02.04.00.00 
Propranolol 80mg modified-release 
capsules 
97105989 02.04.00.00 
PROPRANOLOL 80mg m/r capsules 98041998 02.04.00.00 
Co-tenidone 50mg/12.5mg tablets 98636990 02.04.00.00 
Metoprolol 200mg modified-release / 
Hydrochlorothiazide 25mg tablets 
94634998 02.04.00.00 
PINDOLOL 5mg tablets 91884998 02.04.00.00 
Labetalol 100mg tablets 99538990 02.04.00.00 
Betaxolol 20mg tablets 95957998 02.04.00.00 
PINDOLOL 15mg tablets 98961997 02.04.00.00 
AMILORIDE HCl + ATENOLOL & 
HYDROCHLOROTHIAZIDE caps 
94545998 02.04.00.00 
Sotalol 25mg/5ml oral suspension 85780998 02.04.00.00 
Atenolol 100mg tablets 98798989 02.04.00.00 
Atenolol 25mg tablets 96924990 02.04.00.00 
Carvedilol 3.125mg tablets 94986990 02.04.00.00 
SOTALOL + 
HYDROCHLOROTHIAZIDE tabs 
80mg + 12.5mg 
95267998 02.04.00.00 
Propranolol 160mg modified-release 
capsules 
98451988 02.04.00.00 
METOPROLOL 50mg tablets 96093992 02.04.00.00 
Metoprolol 100mg tablets 98482989 02.04.00.00 
Co-tenidone 100mg/25mg tablets 98344989 02.04.00.00 
Atenolol 25mg tablets 97786990 02.04.00.00 
PROPRANOLOL oral soln 80mg/5ml 92827996 02.04.00.00 
Atenolol 50mg tablets 97786989 02.04.00.00 
Propranolol 160mg modified-release 
capsules 
99322989 02.04.00.00 
PENBUTOL+FRUSEM 40/20mg tabs 98775998 02.04.00.00 
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TIMOLOL MALEATE + 
BENDROFLUMETHIAZIDE tabs 20mg 
+ 5mg 
95161997 02.04.00.00 
Atenolol 100mg tablets 98143989 02.04.00.00 
Propranolol 160mg modified-release 
capsules 
97943990 02.04.00.00 
Atenolol 100mg tablets 96924988 02.04.00.00 
BISOPROLOL FUMARAT 1.25mg tabs 92810990 02.04.00.00 
METOPROLOL 50mg tablets 96043998 02.04.00.00 
Sotalol 40mg tablets 95651990 02.04.00.00 
Propranolol 10mg tablets 99417990 02.04.00.00 
Atenolol 25mg tablets 97968990 02.04.00.00 
Sotalol 80mg tablets 97136989 02.04.00.00 
Metoprolol 100mg tablets 97740989 02.04.00.00 
Labetalol 200mg tablets 99538989 02.04.00.00 
Propranolol 80mg modified-release 
capsules 
97943989 02.04.00.00 
Atenolol 50mg tablets 97137989 02.04.00.00 
CO-TENIDONE 100/25mg tablets 97710997 02.04.00.00 
METOPROLOL 100mg tablets 96828992 02.04.00.00 
BISOPROLOL FUMARAT 1.25mg tabs 86099998 02.04.00.00 
Sotalol 80mg tablets 96714990 02.04.00.00 
Co-tenidone 50mg/12.5mg tablets 98181989 02.04.00.00 
Bisoprolol 10mg tablets 96346989 02.04.00.00 
Metoprolol 100mg tablets 96849989 02.04.00.00 
Atenolol 100mg tablets 97968988 02.04.00.00 
Atenolol 50mg tablets 99277990 02.04.00.00 
Celiprolol 400mg tablets 96711989 02.04.00.00 
TIMOLOL MALEATE + AMILORIDE 
& HYDROCHLOROTHIAZIDE tabs 
94551998 02.04.00.00 
Carvedilol 12.5mg tablets 94989990 02.04.00.00 
Nadolol 80mg / Bendroflumethiazide 
5mg tablets 
95765997 02.04.00.00 




PROPRANOLOL caps 2.5mg + 80mg 
95014998 02.04.00.00 
METOPROLOL 100mg tablets 96043997 02.04.00.00 
PROPRANOLOL 160mg m/r capsules 87881998 02.04.00.00 
OXPRENOLOL 160mg m/r tablets 92926998 02.04.00.00 
Bisoprolol 5mg tablets 96243990 02.04.00.00 
Propranolol 40mg tablets 96238989 02.04.00.00 
Metoprolol 50mg tablets 98650990 02.04.00.00 
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BENDROFLUMETHIAZIDE + 
NADOLOL tabs 5mg + 40mg 
95012998 02.04.00.00 
Bisoprolol 5mg/5ml oral suspension 86051998 02.04.00.00 
BISOPROLOL FUMARATE 5mg tabs 88161998 02.04.00.00 
Bisoprolol 5mg tablets 96337990 02.04.00.00 
Oxprenolol 160mg modified-release 
tablets 
99707989 02.04.00.00 
Propranolol 160mg modified-release 
capsules 
95265990 02.04.00.00 
Co-tenidone 50mg/12.5mg tablets 97769990 02.04.00.00 
Celiprolol 200mg tablets 96065990 02.04.00.00 
Sotalol 40mg tablets 96101990 02.04.00.00 
Sotalol 80mg tablets 97222990 02.04.00.00 
Bisoprolol 5mg tablets 96346990 02.04.00.00 
PROPRANOLOL 160mg tablets 96025998 02.04.00.00 
METOPROLOL 50mg tablets 81243998 02.04.00.00 
PINDOLOL 15mg tablets 91887998 02.04.00.00 
Labetalol 400mg tablets 99538988 02.04.00.00 
PROPRANOLOL 80mg m/r capsules 97691998 02.04.00.00 
LABETALOL TAB 93798992 02.04.00.00 
Metoprolol 12.5mg capsules 82069998 02.04.00.00 
Propranolol 10mg tablets 96004990 02.04.00.00 
Propranolol 10mg tablets 96238990 02.04.00.00 
Propranolol 40mg tablets 98450990 02.04.00.00 
CARTEOLOL HCl tabs 10mg 93905998 02.04.00.00 
METOPROLOL 100mg tablets 81242998 02.04.00.00 
Propranolol 40mg tablets 99417989 02.04.00.00 
HYDROCHLOROTHIAZIDE + 
ATENOLOL & AMILORIDE caps 
94671998 02.04.00.00 
FUROSEMIDE + PENBUTOLOL tabs 96473998 02.04.00.00 
Metoprolol 50mg tablets 95468990 02.04.00.00 
CO-TENIDONE 50/12.5mg tablets 91079998 02.04.00.00 
Propranolol 5mg/5ml oral solution sugar 
free 
99817979 02.04.00.00 
Metoprolol 100mg tablets 97801989 02.04.00.00 
BISOPROLOL FUMARATE 10mg tabs 88160998 02.04.00.00 
Labetalol 400mg tablets 95253990 02.04.00.00 
BENDROFLUMETHIAZIDE + 
PROPRANOLOL mr cap 5mg + 160mg 
95014997 02.04.00.00 
Atenolol 50mg tablets 97968989 02.04.00.00 
PROPRANOLOL 10 MG SUS 95514992 02.04.00.00 
BISOPROLOL oral susp 1.5mg/5ml 85844998 02.04.00.00 
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CLOPAMIDE + PINDOLOL tabs 5mg + 
10mg 
96630998 02.04.00.00 






Carvedilol 12.5mg tablets 94984990 02.04.00.00 
Atenolol 25mg tablets 97137990 02.04.00.00 
BISOPROLOL FUMARATE 10mg tabs 92151998 02.04.00.00 
Labetalol 400mg tablets 98361988 02.04.00.00 
Atenolol 100mg tablets 88077996 02.04.00.00 
Carvedilol 6.25mg tablets 94990990 02.04.00.00 
Propranolol 80mg modified-release 
capsules 
97983990 02.04.00.00 
Co-tenidone 100mg/25mg tablets 98181990 02.04.00.00 
PROPRANOLOL 80mg m/r capsules 88890998 02.04.00.00 
Celiprolol 400mg tablets 96735989 02.04.00.00 
Labetalol 100mg tablets 96856990 02.04.00.00 
PROPRANOLOL 160mg tablets 98298998 02.04.00.00 
Bisoprolol 5mg tablets 96002990 02.04.00.00 
HYDROCHLOROTHIAZIDE + 
METOPROLOL TARTRATE tabs 
12.5mg + 100mg 
94633997 02.04.00.00 
METOPROLOL FUMARATE 190 MG 
TAB 
96332992 02.04.00.00 
Carvedilol 5mg/5ml oral suspension 81052998 02.04.00.00 
LABETALOL 100mg/20mL injection 99033998 02.04.00.00 
CO-TENIDONE 100/25mg tablets 91079997 02.04.00.00 
Propranolol 80mg tablets 98451990 02.04.00.00 
Sotalol 160mg tablets 97222989 02.04.00.00 
Co-tenidone 100mg/25mg tablets 97769989 02.04.00.00 
CO-TENIDONE 50/12.5mg tablets 97710998 02.04.00.00 
Acebutolol 200mg capsules 93851990 02.04.00.00 
Propranolol 50mg/5ml oral solution 
sugar free 
99816979 02.04.00.00 
Bisoprolol 10mg tablets 96337989 02.04.00.00 
PROPRANOLOL 80mg m/r capsules 88405998 02.04.00.00 
Propranolol 40mg tablets 96003990 02.04.00.00 
Atenolol 100mg tablets 97786988 02.04.00.00 
Propranolol 80mg tablets 99417988 02.04.00.00 
Sotalol 40mg tablets 95505990 02.04.00.00 
Propranolol 10mg tablets 93886990 02.04.00.00 
PROPRANOLOL 10mg tablets 97590998 02.04.00.00 
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CO-TENIDONE 50/12.5mg tablets 93345992 02.04.00.00 
Propranolol 160mg tablets 99419988 02.04.00.00 
METOPROLOL FUMARATE 95 MG 
TAB 
96710992 02.04.00.00 
Celiprolol 400mg tablets 96719989 02.04.00.00 
Bisoprolol 10mg tablets 96276989 02.04.00.00 
PROPRANOLOL 160mg m/r capsules 91837998 02.04.00.00 
Oxprenolol 40mg tablets 99712989 02.04.00.00 
Carvedilol 6.25mg tablets 94985990 02.04.00.00 
Carvedilol 3.125mg tablets 94991990 02.04.00.00 
ATENOLOL 50mg tablets 93563998 02.04.00.00 
PROPRANOLOL 160mg m/r capsules 88388998 02.04.00.00 
Co-tenidone 100mg/25mg tablets 96895989 02.04.00.00 
Bisoprolol 2.5mg tablets 93342990 02.04.00.00 
PROPRANOLOL 160mg m/r capsules 94493998 02.04.00.00 
PROPRANOLOL POWDERS 5 MG 
POW 
94320992 02.04.00.00 
Labetalol 200mg tablets 99539989 02.04.00.00 
CO-TENIDONE 100/25mg tablets 93344992 02.04.00.00 
METOPROLOL FUMARATE 95mg 
tabs 
94497998 02.04.00.00 
OXPRENOLOL 10 MG TAB 94258992 02.04.00.00 
CARTEOLOL 10mg tablets 93937998 02.04.00.00 
Acebutolol 400mg tablets 93850990 02.04.00.00 
BISOPROLOL FUMARATE 2.5mg tabs 58692979 02.04.00.00 
PROPRANOLOL 160mg m/r capsules 88521998 02.04.00.00 
Labetalol 100mg tablets 97745990 02.04.00.00 
Labetalol 100mg tablets 99539990 02.04.00.00 
Propranolol 80mg modified-release 
capsules 
94682990 02.04.00.00 
METOPROLOL TARTRATE oral susp 
12.5mg/5ml 
80949998 02.04.00.00 
Propranolol 80mg modified-release 
capsules 
81718998 02.04.00.00 
Metoprolol 12.5mg/5ml oral suspension 79472979 02.04.00.00 
PROPRANOLOL 80mg m/r capsules 81022998 02.04.00.00 
LABETALOL 100mg tablets 97350998 02.04.00.00 
LABETALOL 200mg tablets 97350997 02.04.00.00 
PROPRANOLOL 10mg tablets 97104998 02.04.00.00 
Labetalol 200mg tablets 97745989 02.04.00.00 
PROPRANOLOL 40mg tablets 97590997 02.04.00.00 
OXPRENOLOL 80mg tablets 97588996 02.04.00.00 
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Carvedilol 3.125mg tablets 94967990 02.04.00.00 
Propranolol 80mg modified-release 
capsules 
99088988 02.04.00.00 
BISOPROLOL FUMARAT 1.25mg tabs 58693979 02.04.00.00 
Propranolol 160mg modified-release 
capsules 
81067998 02.04.00.00 
Propranolol 160mg modified-release 
capsules 
94681990 02.04.00.00 
Bisoprolol 1.25mg tablets 93149990 02.04.00.00 
PROPRANOLOL 80mg m/r capsules 93625992 02.04.00.00 
Bisoprolol 1.25mg tablets 91779990 02.04.00.00 
Nebivolol 2.5mg tablets 92343990 02.04.00.00 
Bisoprolol 1.25mg tablets 92013990 02.04.00.00 
PROPRANOLOL 160mg m/r capsules 91766998 02.04.00.00 
HYDROCHLOROTHIAZIDE 
/METOPROLOL TARTRATE 25 MG 
TAB 
95120992 02.04.00.00 
Carvedilol 3.125mg tablets 94931990 02.04.00.00 
BENDROFLUMETHIAZIDE + 
NADOLOL tabs 5mg + 80mg 
95012997 02.04.00.00 
AMILORIDE HCl + TIMOLOL & 
HYDROCHLOROTHIAZIDE tabs 
94550998 02.04.00.00 
PROPRANOLOL 30 MG SUS 94321992 02.04.00.00 
PROPRANOLOL paed 4 MG TAB 94319992 02.04.00.00 
Propranolol 80mg tablets 96238988 02.04.00.00 
SOTALOL 40mg/4mL injection 95265998 02.04.00.00 
Co-tenidone 50mg/12.5mg tablets 96895990 02.04.00.00 
Celiprolol 200mg tablets 96735990 02.04.00.00 
OXPRENOLOL 160mg m/r tablets 97098998 02.04.00.00 
LABETALOL 400mg tablets 97350996 02.04.00.00 
Sotalol 80mg tablets 97157990 02.04.00.00 
Propranolol 40mg tablets 99090990 02.04.00.00 
Bisoprolol 1.25mg tablets 93306990 02.04.00.00 
PROPRANOLOL 160mg m/r capsules 81716998 02.04.00.00 
 85507998 23.00.00.00 
HYDROCHLOROTHIAZIDE + 
METOPROLOL TARTRATE mr tab 
25mg + 200mg 
94633998 02.04.00.00 
Propranolol 10mg tablets 91554998 02.04.00.00 
PROPRANOL HCL 5mg/5mL s/f soln 91326998 02.04.00.00 
PROPRAN HCL 10mg/5mL s/f soln 91326997 02.04.00.00 
PROPRAN HCL 50mg/5mL s/f soln 91326996 02.04.00.00 
PROPRAN HCL 40mg/5mL s/f soln 83081998 02.04.00.00 
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PROPRANOLOL 15 MG SYR 95516992 02.04.00.00 
 
Antiplatelet Medication Description, Multilex Code, and BNF Code 
Description Multilex Code BNF Code 
ALOXIPRIN tabs 600mg 96955998 04.07.01.00 
ALOXIPRIN tabs 600mg 99292998 04.07.01.00 
ANAGRELIDE 500mcg capsules 87014998 09.01.04.00 
Anagrelide 500microgram capsules 87015998 09.01.04.00 
CLOPIDOGREL 300mg tablets 83921998 02.09.00.00 
CLOPIDOGREL 75mg tablets 82684998 02.09.00.00 
CLOPIDOGREL 75mg tablets 89393998 02.09.00.00 
Clopidogrel 1mg/ml oral suspension 81504998 02.09.00.00 
Clopidogrel 300mg tablets 83922998 02.09.00.00 
Clopidogrel 75mg tablets 89385998 02.09.00.00 
Clopidogrel 75mg tablets 92249990 02.09.00.00 
Clopidogrel 75mg tablets 97615979 02.09.00.00 
Clopidogrel 75mg/5ml oral suspension 81139998 02.09.00.00 
DIPYRID+ASP 200mg/25mg m/r cap 88498998 02.09.00.00 
DIPYRIDAMOLE 100 MG SUS 94142992 02.09.00.00 
DIPYRIDAMOLE 100mg tablets 92941998 02.09.00.00 
DIPYRIDAMOLE 100mg tablets 94160997 02.09.00.00 
DIPYRIDAMOLE 100mg tablets 96183997 02.09.00.00 
DIPYRIDAMOLE 100mg tablets 96340992 02.09.00.00 
DIPYRIDAMOLE 100mg tablets 99263997 02.09.00.00 
DIPYRIDAMOLE 200mg m/r caps 89165998 02.09.00.00 
DIPYRIDAMOLE 25mg tablets 92941997 02.09.00.00 
DIPYRIDAMOLE 25mg tablets 94160998 02.09.00.00 
DIPYRIDAMOLE 25mg tablets 96183998 02.09.00.00 
DIPYRIDAMOLE 25mg tablets 99263998 02.09.00.00 
DIPYRIDAMOLE oral liq 85499998 02.09.00.00 
Dipyridamole 100mg tablets 95615990 02.09.00.00 
Dipyridamole 100mg tablets 96344997 02.09.00.00 
Dipyridamole 100mg tablets 97763989 02.09.00.00 
Dipyridamole 100mg tablets 99225990 02.09.00.00 
Dipyridamole 100mg tablets 99228990 02.09.00.00 















Aspirin Description, Multilex Code, and BNF Code 
Description Multilex Code BNF Code 
Aspirin 75mg dispersible tablets 98776998 02.09.00.00 
Aspirin 75mg gastro-resistant tablets 98776997 02.09.00.00 
Aspirin 75mg tablets 93575998 02.09.00.00 
Aspirin 300mg gastro-resistant tablets 94254998 04.07.01.00 
Aspirin 300mg dispersible tablets 98419997 10.01.01.00 
Aspirin 300mg tablets 98419998 10.01.01.00 
ASPIRIN 75mg e/c tablets 99334996 02.09.00.00 
Dipyridamole 200mg modified-release / 
Aspirin 25mg capsules 
88500998 02.09.00.00 
ASPIRIN 300mg e/c tablets 99334998 04.07.01.00 
ASPIRIN 75mg e/c tablets 89218998 02.09.00.00 
Aspirin 75mg dispersible tablets 99808990 02.09.00.00 
Aspirin 75mg dispersible tablets 97918990 02.09.00.00 
ASPIRIN 300mg e/c tablets 89217998 04.07.01.00 
Dipyridamole 100mg/5ml oral 
suspension 
85500998 02.09.00.00 
Dipyridamole 200mg modified-release / 
Aspirin 25mg capsules 
88500998 02.09.00.00 
Dipyridamole 200mg modified-release 
capsules 
96344996 02.09.00.00 
Dipyridamole 25mg tablets 96344998 02.09.00.00 
Dipyridamole 25mg tablets 99226989 02.09.00.00 
Dipyridamole 50mg/5ml oral suspension 
sugar free 
88829998 02.09.00.00 
PERSANTIN 10 MG SUS 95401992 02.09.00.00 
PERSANTIN 100 MG SUS 95400992 02.09.00.00 
PRASUGREL 10mg tablets 83026998 02.09.00.00 
Prasugrel 10mg tablets 83028998 02.09.00.00 
Prasugrel 5mg tablets 83029998 02.09.00.00 
TICAGRELOR 90mg tablets 81711998 02.09.00.00 
TICLOPIDINE HCL 250mg tablets 97794998 02.09.00.00 
Ticagrelor 90mg tablets 81712998 02.09.00.00 
Ticlopidine 250mg tablets 89136998 02.09.00.00 
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ASPIRIN 75mg disp tabs 91537998 02.09.00.00 
ASPIRIN 100mg m/r tablets 96877992 02.09.00.00 
ASPIRIN 75mg e/c tablets 91537997 02.09.00.00 
ASPIRIN 150 MG TAB 94665992 04.07.01.00 
ASPIRIN mr tab 100mg 98776996 02.09.00.00 
Aspirin 75mg gastro-resistant tablets 97160990 02.09.00.00 
ASPIRIN 100mg eff tabs 94589998 02.09.00.00 
ASPIRIN 75mg e/c tablets 90711998 02.09.00.00 
Aspirin 75mg gastro-resistant tablets 97537990 02.09.00.00 
ASPIRIN 100mg m/r tablets 93099998 02.09.00.00 
ASPIRIN + DIPYRIDAMOLE mr cap 
25mg + 200mg 
88496998 02.09.00.00 
ISMN+ASPIRIN 60/75mg m/r tabs 90734998 02.06.01.00 
Aspirin 75mg dispersible tablets 98592990 02.09.00.00 
Aspirin 75mg / Isosorbide mononitrate 
60mg modified-release tablets 
90731998 02.06.01.00 
Aspirin 75mg dispersible tablets 97241990 02.09.00.00 
ASPIRIN 75mg e/c tablets 92015998 02.09.00.00 
Aspirin 300mg effervescent tablets sugar 
free 
94709997 02.09.00.00 
Aspirin 75mg dispersible tablets 99807990 02.09.00.00 
ASPIRIN PAED 81 MG TAB 96110992 04.07.01.00 
Aspirin 300mg dispersible tablets 99808989 10.01.01.00 
Aspirin 300mg modified-release tablets 94216997 02.09.00.00 
ASPIRIN 75mg tablets 93576998 02.09.00.00 
ASPRIN E/C 324 MG TAB 96843992 04.07.01.00 
Aspirin 75mg gastro-resistant tablets 97241989 02.09.00.00 
ASPIRIN 300mg m/r tablets 93099997 02.09.00.00 
ASPIRIN SR 100 MG TAB 96878992 02.09.00.00 
ASPIRIN SOLUBLE 150 MG TAB 94680992 04.07.01.00 
Aspirin 75mg gastro-resistant tablets 99282988 02.09.00.00 
ASPIRIN SR 300 MG TAB 96569992 02.09.00.00 
ASPIRIN 75mg e/c tablets 89625998 02.09.00.00 
ASPIRIN 300mg e/c tablets 94214997 04.07.01.00 
ASPIRIN mr cap 162.5mg 83014998 02.09.00.00 
ASPIRIN 300mg e/c tablets 92706998 02.09.00.00 
Aspirin 75mg dispersible tablets 97677989 02.09.00.00 
ASPIRIN disp 150 MG TAB 94670992 04.07.01.00 
ASPIRIN caps 162.5mg 94709996 02.09.00.00 
ASPIRIN SOLUBLE 100 MG TAB 94669992 02.09.00.00 
ASPIRIN 324mg e/c tablets 97088992 04.07.01.00 
ASPIRIN eff tabs 300mg 94513997 02.09.00.00 
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Aspirin 300mg orodispersible tablets 
sugar free 
91841998 10.01.01.00 
ASPIRIN SOLUBLE 200 MG TAB 94076992 04.07.01.00 
ASPIRIN 300mg disp tabs 93368998 04.07.01.00 
Aspirin 75mg dispersible tablets 98513989 02.09.00.00 
Aspirin 75mg dispersible tablets 98142990 02.09.00.00 
Aspirin 300mg tablets 99808988 10.01.01.00 
ASPIRIN 75mg e/c tablets 88820998 02.09.00.00 
ASPIRIN eff tabs 100mg 94513998 02.09.00.00 
Aspirin 75mg gastro-resistant tablets 97097990 02.09.00.00 
Aspirin 150mg / Isosorbide mononitrate 
60mg modified-release tablets 
90731997 02.06.01.00 
ISMN+ASPIRIN 60/150mg m/r tab 90733998 02.06.01.00 
Aspirin 75mg gastro-resistant tablets 96390990 02.09.00.00 
Aspirin 300mg dispersible tablets 99807989 10.01.01.00 
Aspirin 75mg dispersible tablets 99282989 02.09.00.00 
Aspirin 300mg gastro-resistant tablets 97935990 04.07.01.00 
ASPIRIN SOLUBLE 600 MG TAB 94020992 02.09.00.00 
Aspirin 300mg gastro-resistant tablets 97181990 04.07.01.00 
Aspirin 300mg dispersible tablets 98592988 10.01.01.00 
ASPIRIN mr tab 324mg 94216998 04.07.01.00 
Aspirin 75mg dispersible tablets 99810988 02.09.00.00 
ASPIRIN 300mg disp tabs 97400998 04.07.01.00 
Aspirin 75mg gastro-resistant tablets 97182990 02.09.00.00 
Aspirin 300mg tablets 98513990 10.01.01.00 
Aspirin 75mg dispersible tablets 97160998 02.09.00.00 
Aspirin 75mg dispersible tablets 95352990 02.09.00.00 
Aspirin 75mg gastro-resistant tablets 96988989 02.09.00.00 
ASPIRIN 75mg e/c tablets 90143998 02.09.00.00 
Aspirin 300mg gastro-resistant tablets 97537989 04.07.01.00 
Aspirin 75mg dispersible tablets 96201990 02.09.00.00 
Aspirin 300mg dispersible tablets 98142989 04.07.01.00 
Aspirin 300mg effervescent tablets sugar 
free 
90377998 04.07.01.00 
ASPIRIN 300mg disp tabs 95911992 04.07.01.00 
Aspirin 300mg dispersible tablets 96414990 10.01.01.00 
ASPIRIN 325 MG CAP 94668992 04.07.01.00 
Aspirin 300mg dispersible tablets 97918989 10.01.01.00 
ASPIRIN + GLYCINE dissolving tab 
300mg + 133mg 
94215997 10.01.01.00 
Aspirin 75mg dispersible tablets 96007990 02.09.00.00 
ASPIRIN 325 MG TAB 99876992 04.07.01.00 
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Aspirin 300mg dispersible tablets 97974989 10.01.01.00 
Aspirin 300mg dispersible tablets 96129990 10.01.01.00 
Aspirin 300mg dispersible tablets 96566989 10.01.01.00 
Aspirin 75mg gastro-resistant tablets 96436990 02.09.00.00 
Aspirin 75mg gastro-resistant tablets 94441990 02.09.00.00 
Aspirin 300mg dispersible tablets 99283989 10.01.01.00 
ASPIRIN disp 200 MG TAB 94412992 04.07.01.00 
ASPIRIN 300mg tablets 99824998 04.07.01.00 
Aspirin 75mg dispersible tablets 95310990 02.09.00.00 
ASPIRIN + GLYCINE chewable tab 
300mg + 150mg 
94215996 10.01.01.00 
Aspirin 300mg tablets 91965979 10.01.01.00 
Aspirin 300mg dispersible tablets 95351990 10.01.01.00 
Aspirin 300mg dispersible tablets 99810989 04.07.01.00 
Aspirin 300mg tablets 99807988 10.01.01.00 
Aspirin 75mg gastro-resistant tablets 96444990 02.09.00.00 
ASPIRIN M/F 324 MG TAB 94667992 04.07.01.00 
ASPIRIN 162.5mg m/r capsules 83013998 02.09.00.00 
ASPIRIN 324mg e/c tablets 94214998 04.07.01.00 
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